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ADHD is among the most common childhood psychiatric disorders, estimated to affect 
approximately 3% to 5% of elementary school-aged children, with 11% to 37% reporting 
sleep disturbance (American Psychiatric Association, 2000; Owens, Spirito, McGuinn, & 
Nobile, 2000).  Disturbed sleep can result in daytime sleepiness and behavioral 
difficulties that affect cognitive functions in children, such as attention and memory, as 
well as exacerbate symptoms of ADHD (Fallone, Owens, & Deane, 1998; Owens, 2005).  
The primary aim of this study was to determine the prevalence of ICD-9 sleep disorders, 
prescribed sleep medications, and complaints of sleep problems as diagnosed by pediatric 
primary care providers in children and adolescents with ADHD across medication status, 
ADHD subtype, and comorbidity.  Electronic medical records were reviewed for 5,881 
patients (6-18 years) diagnosed with ADHD and 5,881 patients without ADHD matched 
by age, gender, and primary care practice and seen for a well-child visit in 2007.  
Information was collected on ICD-9 sleep diagnoses, medications potentially used to treat 
sleep disorders, demographic variables, medications commonly used to treat symptoms of 
ADHD, ICD-9 ADHD subtype, and comorbidity.  A secondary analysis was conducted 
on 556 participants to examine parent and/or patient complaint of sleep problems.  
Results indicated that children and adolescents with ADHD were more likely to be 
diagnosed with a sleep disorder or prescribed a sleep medication compared to their 
pediatric counterparts with no ADHD diagnosis.  The significance of medications 
commonly used to treat symptoms of ADHD, ICD-9 ADHD subtype, and comorbidity as 
risk factors of sleep disturbance was discussed.  This is one of the first studies to 
highlight the subgroups of children and adolescents with ADHD significantly more likely 
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to exhibit sleep disturbance across a large primary care network.  These risk factors and 
their subsequent effects on the severity of symptoms associated with ADHD must be 
considered when assessing and treating children and adolescents with ADHD.   
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CHAPTER I. INTRODUCTION 
Attention Deficit Hyperactivity Disorder (ADHD) is composed of three core 
characteristics:  Inattention, impulsivity, and overactivity (American Psychiatric 
Association, 2000).  It is among the most common childhood psychiatric disorders, 
estimated to affect approximately 3% to 5% of elementary school-aged children 
(American Psychiatric Association, 2000).  Although the association between ADHD and 
other psychiatric and developmental disorders such as oppositional defiant disorder, 
anxiety disorders, depressive disorders, and speech and learning disorders has been 
extensively studied, the association between ADHD and sleep disturbances has been 
relatively overlooked (Lecendreux & Cortese, 2007).   
 Sleep disturbance includes diagnosed sleep disorders, such as obstructive sleep 
apnea, restless legs syndrome, periodic limb movement disorder, enuresis, and 
narcolepsy, and complaints of sleep problems, including daytime sleepiness, change in 
sleep location, difficulty falling asleep, waking during the night, early morning waking, 
and restless sleep (Brown & McMullen, 2001; Owens, 2005).  These sleep problems are 
often signs of an underlying sleep disorder.  Sleep disturbance in children and adolescents 
is commonly treated through medical (i.e., tonsilloadenoidectomy or continuous positive 
airway pressure) or behavioral (behavioral sleep training) interventions (Mindell, Owens, 
& Carskadon, 1999).  Although the Food and Drug Administration (FDA) does not 
currently approve any medications for the treatment of sleep disorders in children and 
adolescents, several studies have found that primary care physicians frequently prescribe 
medications to treat sleep disturbance in this population (Owens, Rosen, & Mindell, 
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2003; Rappley, Luo, Brady, & Gardiner, 2003; Stojanovski, Rasu, Balkishnan, & Nahata, 
2007).   
Estimates of parent-reported sleep disturbance in school age children range from 
11% to 37% (Owens, Spirito, McGuinn, & Nobile, 2000).  Specifically within the 
population of children and adolescents with ADHD, it is estimated that 25% to 50% 
present with sleep disturbance (Corkum, Tannock, Moldufsky, 1998).  Sleep complaints 
in children with ADHD were so common that restless and disturbed sleep were part of 
previous versions of the DSM diagnostic criteria for ADHD (Owens, 2005), although 
these sleep problems have not been included in the last three versions of the DSM 
(American Psychiatric Association, 1987, 1994, 2000).  
Insufficient and/or poor quality sleep can result in daytime sleepiness and 
behavioral difficulties that affect cognitive functions in children, such as attention and 
memory (Fallone, Owens, & Deane, 1998).  In addition, sleep loss can have a direct 
impact on mood as symptoms associated with ADHD may be exacerbated by sleep 
problems (Owens, 2005).  For example, rather than getting tired and lethargic like adults, 
children deprived of sleep typically display restlessness, irritability, and are easily 
frustrated (Anstead, 2000).  Further, psychotropic medications commonly used to treat 
symptoms of ADHD in children may result in sleep problems (Corkum, Tannock, & 
Moldofsky, 1998).  As a result, sleep disturbance in children with ADHD can have a 
negative impact on the severity of ADHD symptoms present during the day as well as 
pose a challenge for clinicians in developing effective treatment strategies.  Given the 
importance of sleep issues in the diagnosis and treatment of ADHD, it is important to 
understand the variety of ways in which ADHD and sleep can interact.  It is clear that 
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sleep disturbance in children and adolescents with ADHD has the potential to impact 
ADHD related symptoms.  Further, this relationship may be moderated by medication, 
subtype, and comorbid diagnoses.  
Medication Status 
Stimulant medication (e.g., methylphenidate or MPH) is the most common 
treatment for ADHD, as 70-90% of children with ADHD who receive treatment are 
treated with stimulants alone or in combination with behavioral strategies (Jensen et al., 
1999).  Stimulant medications provide an immediate reduction in symptoms associated 
with ADHD that continues for as long as an adequate level of medication is sustained 
(Greenhill, Beyer, & Finkleson, 2002).  In addition, stimulant medication also produces a 
decreased need for sleep and awareness of fatigue (Bricard & Boiden, 2001).  Although 
some studies found differences in sleep problems between children with ADHD treated 
with stimulant medication, unmedicated children with ADHD, and children without 
ADHD (Corkum et al., 2007; Galland, Tripp, & Taylor, 2010; Mayes et al., 2009; 
Schwartz et al., 2004; Stein, 1999), other studies indicate that there are no differences in 
sleep between medicated and unmedicated children with ADHD (O’Brien et al., 2003).  
ADHD Subtype 
 The Diagnostic and Statistical Manual, Fourth Edition, Text Revision (American 
Psychological Association, 2000) identifies three subtypes of ADHD: Predominantly 
Inattentive Type, Predominantly Hyperactive-Impulsive Type, and Combined Type.  The 
International Classification of Diseases, Ninth Revision (ICD-9) is the diagnostic criteria 
used in primary care facilities and classifies ADHD subtypes as with and without 
mention of hyperactivity, essentially collapsing the Predominantly Hyperactive-
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Impulsive Type and Combined Type.  As ADHD subtypes differ regarding diagnostic 
criteria and functional impairment (American Psychological Association, 2000), it is 
necessary to investigate sleep problems across both subtypes.  Several studies offer 
conflicting results regarding differences in sleep quality, dyssomnias, and daytime 
sleepiness between ADHD subtypes.  Although LeBourgeois et al. (2004) suggested that 
there were no differences in sleep quality among subtypes of ADHD, Corkum et al. 
(1999) found subtype differences in sleep-related involuntary movements .  Lecendruex 
et al. (2000) found that children with elevated levels of hyperactivity fell asleep faster at 
night and more often during the day compared to children with elevated levels of 
inattention.  Similarly, Chiang et al. (2010) found that children with ADHD-Combined 
Type had higher relative rates of circadian rhythm problems, sleep talking, and 
nightmares whereas children with ADHD-Inattentive Type had higher relative rates of 
hypersomnia.  In contrast, other results have indicated that differences in dyssomnias 
were not significant when psychiatric comorbidity was controlled (Corkum et al., 1999; 
Willoughby et al., 2008).  Although several investigators found that daytime sleepiness 
was more common in children with ADHD compared to controls and was greatest in 
ADHD-Inattentive type compared to other subtypes of ADHD (LeBourgeois et al., 2004; 
Mayes et al., 2009; Willoughby et al., 2008), others noted that children with elevated 
levels of hyperactivity fell asleep more often during the day (Lecendreux et al., 2000).  
Comorbidity 
Children with ADHD are at increased risk for developing a comorbid psychiatric 
diagnosis, such as anxiety disorder, depression, oppositional defiant disorder, and 
conduct disorder, when compared to children without ADHD (Biederman, 2005; Jensen 
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et al., 2001).  It is currently estimated that 65% of children with ADHD may have a 
comorbid psychiatric disorder (Bartholomew & Owens, 2006).  Despite documentation 
that common comorbid conditions appear to be an important influence on sleep behavior, 
few studies have investigated or controlled for the effect of psychiatric comorbidity on 
sleep problems (Cortese et al., 2006).  ADHD with comorbid oppositional defiant 
disorder has been linked with increased rates of dyssomnias (Corkum et al., 1999).  
Similarly, ADHD with comorbid anxiety disorders is associated with increased levels of 
sleep-related involuntary movements (Ivanenko et al., 2006).  Finally, Mayes et al. 
(2009) concluded that comorbid internalizing disorders increased sleep problems whereas 
comorbid externalizing disorders, such as oppositional defiant disorder, did not.  
Limitations of the Literature 
Taken together, most studies in this body of literature included relatively small 
samples and none examined children with ADHD in the setting where they are most 
commonly treated – primary care.  In addition, none of these studies compared the effects 
of different types of medication commonly used to treat ADHD (i.e., non-stimulant 
medication, stimulant medication, and no medication) on sleep problems or disorders.  
Similarly, most studies excluded children with ADHD and a documented comorbid 
condition, and none of the studies included participants with both a comorbid 
internalizing and externalizing condition. Finally, the samples typically examined sleep 
problems in a narrow age range (i.e., included only children or only adolescents) and only 
examined diagnosed sleep disorders, instead of including sleep problems and medications 
commonly used to treat sleep disturbance.   
Purpose of the Proposed Study 
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The purpose of this study was to determine the prevalence of sleep disturbance in 
children and adolescents with and without ADHD.  This was accomplished by examining 
diagnosed sleep disorders, complaints of sleep problems, and medications commonly 
used to treat sleep disturbance.  In addition, this study explored the frequency, type, and 
significance of sleep disturbance reported to the primary care provider during a well-child 
visit in children and adolescents diagnosed with ADHD.  This analysis focused on 
improving the understanding of the epidemiology of sleep problems in children and 
adolescents with ADHD reported to the primary care provider and thereby strengthening 
the design of more effective identification, prevention, and intervention strategies. 
The specific research questions of the proposed study were:  
1.0 Is ADHD a predictor of sleep disorders and use of sleep medication in children (ages 
6-12) and adolescents (ages 13-18)? 
1.01 It was hypothesized that children and adolescents with ADHD will be 
diagnosed with more sleep disorders compared to normal controls.   
1.02 It was hypothesized that children and adolescents with ADHD will be 
prescribed more sleep medications compared to normal controls. 
2.0 In children (ages 6-12) and adolescents (ages 13-18) with ADHD, to what degree are 
ADHD medication status, ADHD subtype, and psychiatric comorbidity predictive of 
sleep disorders, use of sleep medication, and sleep problems? 
2.01. It was hypothesized that in both children and adolescents with ADHD, 
stimulant medication will be predictive of sleep problems. 
2.02 It was hypothesized that in both children and adolescents with ADHD, 
stimulant medication will not be predictive of sleep disorders.   
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2.03 It was hypothesized that in children and adolescents with ADHD, stimulant 
medication will be predictive of sleep medication. 
2.04 It was hypothesized that in children and adolescents with ADHD, ADHD 
subtype will not be predictive of sleep problems.   
2.05 It was hypothesized that in children and adolescents with ADHD, ADHD 
with hyperactivity will be predictive of sleep disorders.    
2.06 It was hypothesized that in children and adolescents with ADHD, the 
presence of a diagnosed psychiatric comorbidity (internalizing, externalizing, or 
both internalizing and externalizing) will be predictive of sleep problems.  
2.07 It was hypothesized that in children and adolescents with ADHD, the 
presence of a diagnosed psychiatric comorbidity (internalizing, externalizing, or 
both internalizing and externalizing) will be predictive of sleep disorders. 
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CHAPTER II. LITERATURE REVIEW 
Attention Deficit Hyperactivity Disorder (ADHD) 
ADHD is composed of three core characteristics: Inattention, impulsivity, and 
overactivity (American Psychiatric Association, 2000).  It is among the most common 
childhood psychiatric disorders, estimated to affect approximately 3% to 5% of 
elementary school-aged children (American Psychiatric Association, 2000). ADHD is 
associated with several other difficulties, including deficits in academic skills, 
oppositional and defiant behavior, conduct problems, and internalizing symptoms, such 
as anxiety and depression (Smith, Barkley, & Shapiro, 2007). 
These three symptom clusters (inattention, impulsivity, and overactivity), by 
definition, can influence many areas of a child’s life and are associated with impairments 
in academics, disturbances in peer relationships, and conflict with parents and figures of 
authority (American Psychiatric Association, 2000; Barkley, 2006).  Specifically, 
students with this disorder are at increased risk for special education placement, school 
dropout, and lower rates of completion of post-secondary education (Barkley, Murphy, & 
Fischer, 2008).   
Children with ADHD may have difficulty sustaining attention to teacher 
instructions and classroom activities (e.g. circle time, independent seat work) due to high 
levels of off-task and disruptive behavior.  Students with this disorder frequently do not 
complete assigned tasks or do so in a hasty, inaccurate fashion (Barkley, 2006; DuPaul & 
Stoner, 2003).  There also are reports of high rates of noncompliance and aggression 
toward parents, teachers, other authority figures, and peers (Barkley, 2006).  These 
factors demand more time and resources from a teacher, add to the stress level of the 
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teacher, and further hinder the academic success of the child.  It is important to note that 
these academic difficulties may appear early, as preschool children with ADHD have 
been shown to perform significantly below preschool children without ADHD on tests of 
pre-literacy skills (DuPaul, McGoey, Eckert, & VanBrakle, 2001).    
The behavioral symptoms of ADHD (i.e., inattention and hyperactivity-
impulsivity) cause problems in learning new material and completing tasks (DuPaul & 
Stoner, 2003).  Children with ADHD are at greater risk for academic difficulties, below 
average academic achievement, school dropout, and failure (Cole, Usher, & Cargo, 1993; 
Hinshaw, 1992).  In addition, children with this disorder are at-risk for grade retention 
and/or referral for special education services (Barkley, 2006; DuPaul & Stoner, 2003).  
They may also exhibit expressive language skills that are well below average (Bain, 
2001; McGee et al., 1991) at levels that are similar to that of children with pervasive 
developmental disorders (Stein, Szumowski, Blondis, & Roizen, 1995).  Further, 
approximately 30% of children with ADHD have one or more learning disability 
(Barkley, 2006; DuPaul & Stoner, 2003). 
In addition to the problems surfacing in academic performance, children with 
ADHD commonly have trouble creating and maintaining healthy peer relationships and 
are often rejected by same-aged peers (DuPaul & Stoner, 2003).  Children with ADHD 
have difficulty initiating and maintaining friendships because of impulsive behavior.  
They break social norms on a regular basis by barging in on games or by not following 
game rules, usually because they cannot maintain their attention when learning the rules 
and/or receiving direction.  These deficiencies may also cause some children to have 
difficulties maintaining a conversation with others because they lack the ability to keep 
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their attention focused on one thing.  Social problems do not result because they do not 
have the skills to interact with others; rather, children with ADHD have problems 
exhibiting these skills on a consistent basis (Barkley, 2006).   
These behavioral difficulties are frequently associated with peer rejection (Erhardt & 
Hinshaw, 1994) resulting in an increased risk of academic failure and school dropout 
(Lane, 1999).  Similar to academic difficulties that can emerge early in life, there is also 
evidence that social difficulties can be present as early as preschool.  For example, young 
children with ADHD exhibited more negative social behavior during peer interactions 
and had poorer social skills than peers without ADHD as rated by both parents and 
teachers (DuPaul, McGoey, Eckert, & VanBrakle, 2001).  Importantly, these difficulties 
in the social domain may persist from childhood to adolescence, even if the child no 
longer meets criteria for ADHD (Bagwell, Molina, Pelham, & Hoza, 2001).         
Sleep Disturbance 
Sleep disturbance includes diagnosed sleep disorders, such as obstructive sleep 
apnea, restless legs syndrome, periodic limb movement disorder, enuresis, and 
narcolepsy, and complaints of sleep problems, including daytime sleepiness, change in 
sleep location, difficulty falling asleep, waking during the night, early morning waking, 
and restless sleep (Brown & McMullen, 2001; Owens, 2005). These sleep problems are 
often signs of an underlying sleep disorder.  Sleep disturbance is children and adolescents 
is commonly treated through medical (i.e., tonsilloadenoidectomy or continuous positive 
airway pressure) or behavioral (behavioral sleep training) interventions (Mindell, Owens, 
& Carskadon, 1999).  Although the Food and Drug Administration (FDA) does not 
currently approve any medications for the treatment of sleep disorders in children and 
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adolescents, several studies have found that primary care physicians frequently prescribe 
medications to treat sleep disturbance in this population (Owens, Rosen, & Mindell, 
2003; Rappley, Luo, Brady, & Gardiner, 2003; Stojanovski, Rasu, Balkishnan, & Nahata, 
2007).   
   
Estimates of parent-reported sleep disturbance in school age children range from 
11% to 37% (Owens, Spirito, McGuinn, & Nobile, 2000).  This makes sleep disturbance 
one of the most common complaints in pediatric practice (Owens, 2005).  Specifically 
within the population of children and adolescents with ADHD, it is estimated that 25% to 
50% present with sleep disturbance (Corkum, Tannock, Moldufsky, 1998).  So common 
were sleep complaints in children with ADHD that restless and disturbed sleep were part 
of previous versions of the DSM diagnostic criteria for ADHD (Owens, 2005), although 
it has not been included in the last three versions of the DSM (American Psychiatric 
Association, 1987, 1994, 2000). 
Insufficient and/or poor quality sleep can result in daytime sleepiness and 
behavioral difficulties that affect cognitive functions in children, such as attention and 
memory (Fallone, Owens, & Deane, 1998).  In addition, sleep loss can have a direct 
impact on mood as symptoms associated with ADHD may be exacerbated by sleep 
problems (Owens, 2005).  For example, rather than getting tired and lethargic like adults, 
children deprived of sleep typically display restlessness, irritability, and are easily 
frustrated (Anstead, 2000).  Further, psychotropic medications commonly used to treat 
symptoms of ADHD in children may result in sleep problems (Corkum, Tannock, & 
Moldofsky, 1998).  As a result, sleep disturbance in children with ADHD can have a 
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negative impact on the severity of ADHD symptoms during the day as well as pose a 
challenge for clinicians in developing effective treatment strategies.  Given the 
importance of sleep issues in the treatment of ADHD, it is important to understand the 
variety of ways in which ADHD and sleep can interact.       
Sleep Disorders  
Sleep disorders include obstructive sleep apnea (OSA), restless legs syndrome 
(RLS), periodic limb movement disorder (PLMD), and narcolepsy (Owens, 2005).  These 
disorders and subsequent disturbed sleep have been associated with altered mood and 
cognitive performance in adults and children (Cooper et al., 2004).  It is possible that 
these sleep disorders may lead to symptoms of ADHD in children (Chervin, 2001).  In 
contrast, children with ADHD may have intrinsic differences in sleep that are associated 
with these disorders (Golan et al., 2004; Lecendreux et al., 2000).  In other words, 
similarly to the difficulty children with ADHD experience in regulating their behavior 
and emotions, they may also have an innate difficulty regulating their sleep/wake cycle.  
It is important for psychologists and other clinicians to be able to navigate the bi-
directional relationship between sleep and ADHD to ensure optimal diagnosis and 
treatment of children with ADHD.  
One study did not detect differences between children with and without ADHD 
with regards to sleep-disordered breathing.  Cooper et al. (2004) used measures of sleep-
disordered breathing that included nasal resistance and nasal flow, a physical exam, and 
an overnight polysomnography (PSG).  All participants discontinued medication for at 
least 24 hours prior to completing the PSG.  Results did not show group differences in 
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overnight PSG variables indicative of sleep disordered breathing, specifically obstructive 
sleep apnea.    
Several other studies have suggested an association between ADHD and PLMD.  
For example, Picchietti et al. (1999) conducted a neurologic history, physical exam, and 
overnight PSG.  Results indicated that PLMD occurs in a significant subset of children 
diagnosed with ADHD.  Similarly, Crabtree et al. (2003) conducted an overnight PSG on 
all participants and suggested that a large proportion of children with PLMD also had 
ADHD; however, those children with both disorders were significantly more likely to 
have a high number of arousals associated with periodic limb movements (PLM).  More 
research is needed to clarify the directional link between PLMD and ADHD.  
Specifically, fragmented sleep due to PLMD may be linked with hyperactive behavior.  
Alternatively, arousal associated with PLM may be the result of the pathophysiology of 
ADHD (Crabtree et al., 2003). 
Finally, several other studies have demonstrated a link between ADHD symptom 
severity and a family history of RLS as well as a possible association directly between 
ADHD and RLS.  Specifically, parents of children with ADHD are more likely to have 
RLS than parents of children without ADHD (Picchietti et al., 1999).  Further, results 
from Konofal et al. (2007) indicated that ADHD symptoms were more severe in children 
with ADHD and RLS compared to children with only ADHD; however, this difference 
was not statistically significant.  Therefore, it is possible that sleep fragmentation linked 
to RLS may negatively impact daytime behavior and positively contribute to symptoms 
of inattention, hyperactivity, and impulsivity.     
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Overall, studies investigating the association between ADHD and several primary 
sleep disorders included the use of validated measures to assess sleep disorders and 
behavior symptoms.  Despite this, none of the studies controlled for demographic 
characteristics and none of the reviewed studies provided documentation of the 
medications the participants were currently taking, ADHD subtype, or diagnosed 
comorbidity.  These studies only included children and the sample sizes were consistently 
small.  It is possible that a much larger sample size is needed to see significant 
differences in primary sleep disorders, specifically sleep-disordered breathing, between 
children with ADHD and their typically developing peers.    
Sleep Problems   
Sleep problems include daytime sleepiness, change in sleep location, difficulty 
falling asleep, waking during the night, early morning waking, and restless sleep (Brown 
& McMullen, 2001).  It is estimated that 25 to 50% of children with ADHD have 
difficulty initiating and maintaining sleep (Corkum et al., 1998), making insomnia a 
frequently reported problem in mental health practice settings (Owens, 2005).  A 
literature review conducted by Cortese et al. (2009) concluded that children with ADHD 
not currently prescribed stimulant medication had increased parent reports of behavior 
problems at bedtime and early morning as well as objective incidents of fragmented 
sleep, poor sleep efficiency, sleep disordered breathing, and excessive daytime sleepiness 
when compared to children without ADHD.  Prolonged sleep onset latency and restless or 
fragmented sleep can result in significantly shortened sleep duration, insufficient sleep, 
and decreased total sleep efficiency (Owens, 2005).  These problems can be especially 
problematic for children with ADHD, as consequences include daytime sleepiness, 
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difficulty in behavior regulation, and decreased function in the prefrontal cortex, 
specifically involving tasks requiring attention and working memory (Fallone, Owens, 
Deane, 2002).  Further, consequences can include a negative impact on mood, such as 
irritability and decreased positive mood.  Finally, children with sleep problems are 
associated with increased parental stress levels as parent ratings of health-related quality 
of life can be negatively affected (Wolfson, Lacks, Futterman, 1992).  The impact of 
sleep disturbance in children and adolescents with ADHD may be affected by three 
variables that have been overlooked in previous research: medication, subtype, and 
comorbidity.        
Possible Contributing Factors of Sleep Problems  
Medication. Stimulant medication (e.g., methylphenidate or MPH) is the most 
common treatment for ADHD, as 70-90% of children with ADHD are treated with 
stimulants alone or in combination with behavioral strategies (Jensen et al., 1999).  
Current estimates are that 2-9% of children are treated with this type of medication 
(Habel, Schaefer, & Levine, 2005).  Stimulant medications provide an immediate 
reduction in symptoms associated with ADHD, which continues for as long as an 
adequate level of medication is sustained (Greenhill, Beyer, & Finkleson, 2002).  In 
addition, stimulant medication produces a decreased need for sleep and awareness of 
fatigue (Bricard & Boiden, 2001).  Thus, it is reasonable to investigate if children with 
ADHD treated with stimulant medication have increased levels of sleep disturbance.  
Some studies have indicated that children with ADHD and treated with stimulant 
medication report more sleep problems than do children with ADHD who are not treated 
with stimulant medication.  For example, Stein (1999) surveyed the parents of children 
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with ADHD treated with and without stimulant medication, the parents of children with 
other psychiatric disorders, and the parents of children with no psychiatric diagnosis.  
Results indicated that children with ADHD, regardless of the use of medication, had 
more sleep problems when compared to pediatric controls.  Specifically, children with 
ADHD displayed higher rates of insomnia and enuresis compared to the control group.  
Further, parents of children with ADHD treated with stimulant medication were three 
times more likely to report severe sleep problems versus parents of psychiatric or 
pediatric controls.  Similar results were found by Meyes et al. (2009) and Corkum et al. 
(2007) in that children treated with stimulant medication reported greater difficulty 
falling asleep than children with ADHD not treated with stimulant medication.  
Specifically, actigraph and sleep diary data indicated that children treated with stimulant 
medication slept an average of 57 minutes less per night than unmedicated children 
(Corkum et al., 2007).  This significant reduction in sleep was primarily due to delayed 
sleep onset.    Subjective parent reports of sleep problems in this population were further 
validated by Schwartz et al. (2004) through actigraphically recorded sleep parameters, a 
more objective measure of sleep problems.  Results from this study indicated a significant 
increase in activity at sleep onsets and throughout the night resulting in an increase in 
sleep latency and a decrease in sleep efficiency and total sleep time for children receiving 
stimulant medications.   
In order to further investigate these findings that indicate a difference in sleep 
quality and quantity between children with ADHD treated with stimulant medication and 
unmedicated children with ADHD, several studies attempted to control for medication 
status.  Mick et al. (2000) used sleep questionnaires to assess sleep problems and 
19 
 
characteristics in adolescents with ADHD.  When controlling for stimulant medication, 
significant differences in self-reported sleep problems were no longer found between 
adolescents treated with and without stimulant medication.  Similar results were found by 
Corkum et al. (1999), who investigated the relationship between sleep problems and 
medication status in children with and without ADHD.  Results indicated that 
dyssomnias, such as bedtime resistance, sleep onset problems, and difficulty arising, were 
related to confounding factors, such as the use of stimulant medication, rather than a true 
difference in sleep problems between children with and without ADHD. 
Galland, Tripp, and Taylor (2010) used a match case-control design to assess 
sleep-related effects of regular use of methylphenidate.  Specifically, sleep timing, sleep 
duration, and sleep architecture were examined.  Results indicated that the use of 
methylphenidate in children diagnosed with ADHD resulted in prolonged sleep onset by 
an average of 29 minutes and shortened overall sleep duration by an average of 1.2 hours.  
There were no differences noted between children diagnosed with ADHD with and 
without methylphenidate regarding sleep architecture.    
In contrast, some studies have indicated that children with ADHD treated with 
stimulant medication do not have additional sleep problems when compared to 
unmedicated children with ADHD.  For example, O’Brien et al. (2003) gathered 
information through subjective parent reports and objective overnight polysomnogram 
(PSG).  Parents of children with ADHD reported significantly more sleep complaints, 
regardless of medication status, when compared to parent ratings of children without 
ADHD.  Similarly, results of the PSG indicated that children with ADHD, regardless of 
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medication status, had a decreased percentage of rapid eye movement (REM) sleep 
compared to controls. 
Taken together, these studies provide a conflicting picture of the relationship 
between sleep problems and medication status in children and adolescents with ADHD.  
Although some studies found sleep problems between children with ADHD treated with 
stimulant medication, unmedicated children with ADHD, and children without ADHD 
(Corkum et al., 2007; Mayes et al., 2009; Schwartz et al., 2004; Stein, 1999), other 
studies indicate that there are no differences in sleep between medicated and unmedicated 
children with ADHD (O’Brien et al., 2003).  It is important to note, however, that none of 
these studies compared the effects of non-stimulant medication treatment to stimulant 
medication or no medication.  Further, these studies did not examine the relationship 
between sleep problems and ADHD symptom severity in this population.  With the 
exception of Mayes et al. (2009) and Mick et al. (2000), all of the reviewed studies 
utilized a small sample size, limiting the ability to detect true differences between groups.  
Finally, the samples typically included only children or only adolescents. 
ADHD Subtype.  The Diagnostic and Statistical Manual, Fourth Edition, Text 
Revision (American Psychiatric Association, 2000) identifies three subtypes of ADHD: 
Predominantly Inattentive Type, Predominantly Hyperactive-Impulsive Type, and 
Combined Type.  The International Classification of Diseases, Ninth Revision (ICD-9) is 
the diagnostic criteria used in primary care facilities and classifies ADHD subtypes as 
with and without mention of hyperactivity, essentially collapsing the Predominantly 
Hyperactive-Impulsive Type and Combined Type.  As each subtype is characterized by 
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different diagnostic criteria, it is necessary to investigate sleep problems across both 
subtypes.   
Several studies investigated differences in sleep quality between ADHD subtypes.  
For example, LeBourgeois et al. (2004) attempted to determine whether chronic snoring 
is found in relation to each of the ADHD subtypes.  Lower levels of sleep quality were 
reported among children with ADHD compared to control children; however, there were 
no differences in sleep quality among subtypes of ADHD.  In contrast, Corkum et al. 
(1999) found differences in sleep quality between subtypes of ADHD.  Specifically, 
sleep-related involuntary movements, such as talking, bruxism, and restless sleep, were 
associated with children diagnosed with ADHD-Combined Type.  Similarly, Chiang et al. 
(2010) found that a diagnosis of ADHD-Combined subtype was associated with higher 
rates of circadian rhythm problems, sleep talking, and nightmares relative to controls, 
while a diagnosis of ADHD-Inattentive subtype was associated with higher rates of 
hypersomnia relative to controls.     
Another group of studies attempted to explore the relationship between ADHD 
subtype and dyssomnias in children.  Lecendruex et al. (2000) found that children with 
elevated levels of hyperactivity fell asleep faster at night and more often during the day 
compared to children with elevated levels of inattention.  In contrast, results from 
Willoughby et al. (2008) indicated that elevated levels of hyperactive-impulsive 
symptoms were associated with sleep resistance, parasomnias, and dyssomnias.  
However, these effects were not significant when psychiatric comorbidity was controlled.  
Simiarly, Corkum et al. (1999) found that dyssomnias, such as bedtime resistance, sleep 
onset problems, and difficulty arising, were related to confounding factors, such as 
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comorbid oppositional defiant disorder and stimulant medication rather than ADHD 
subtype. 
A final group of studies examined daytime sleepiness across ADHD subtypes.  
Several investigations found that daytime sleepiness was more common in children with 
ADHD compared to controls and was greatest in ADHD-Inattentive type compared to 
other subtypes of ADHD (LeBourgeois et al., 2004; Mayes et al., 2009; Willoughby et 
al., 2008).  Interestingly, Mayes et al. (2009) noted that this relationship was associated 
with children with ADHD-Inattentive type sleeping more during the night compared to 
children with other subtypes of ADHD.  Further, Willoughby et al. (2008) found that 
elevated levels of inattentive symptoms were associated with daytime sleepiness even 
after psychiatric comorbidities were controlled.  In contrast, Lecendreux et al. (2000) 
noted that children with elevated levels of hyperactivity fell asleep more often during the 
day compared to children with elevated levels of inattention and the number of daytime 
sleep onsets were found to accurately discriminate between ADHD subtypes, with 
ADHD-Combined having the most.     
Taken together, the reviewed studies offer conflicting results with regard to sleep 
quality, dyssomnias, and daytime sleepiness across ADHD subtype.  The inability to 
detect group differences and produce a reliable description of sleep problems across 
ADHD subtypes may be due to several common limitations. With the exception of 
Willoughby et al. (2008) and Mayes et al. (2009), most studies contained a relatively 
small sample size.  Finally, the samples typically included only children or only 
adolescents and none of the studies controlled for demographic characteristics, such as 
ethnicity and socioeconomic status   
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Internalizing and Externalizing Comorbidity.  Children with ADHD are at 
increased risk for developing a comorbid psychiatric diagnosis, such as anxiety disorders, 
depression, oppositional defiant disorder, and conduct disorder, when compared to 
children without ADHD (Biederman, 2005; Jenson et al., 2001).  It is currently estimated 
that 65% of children with ADHD may have a comorbid psychiatric disorder 
(Bartholomew & Owens, 2006).  Specifically, oppositional defiant disorder is the most 
common comorbid disorder and can affect 40 to 60% of children with ADHD.  Similarly, 
anxiety disorders are estimated to affect 30% and conduct disorder can affect 14% of 
children with ADHD.  Many comorbid conditions are commonly associated with sleep 
disruption in children (Bartholomew & Owens, 2006).  For example, children with 
anxiety disorders typically display bedtime resistance, refusal to sleep alone, increased 
nighttime fears, and nightmares.  Further, depressive disorders are associated with 
bedtime resistance, delayed sleep onset, problems with sleep maintenance, and excessive 
daytime sleepiness (Mindell & Owens, 2003).  Finally, children with oppositional defiant 
disorder are more likely to demonstrate problems with limit setting and bedtime 
resistance.  Despite documentation that common comorbid conditions appear to be an 
important influence on sleep behavior, few studies have investigated or controlled for the 
effect of psychiatric comorbidity on sleep problems (Cortese et al., 2006).     
 Only three studies have examined the impact of internalizing or externalizing 
comorbidity on sleep problems in children or adolescents with ADHD.  Corkum et al. 
(1999) found that dyssomnias, such as bedtime resistance, sleep onset problems, and 
difficulty arising, were related to comorbid oppositional defiant disorder.  In addition, 
sleep-related involuntary movements, such as sleep talking, bruxism, and restless sleep 
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were associated with separation anxiety disorder.  In another study, Ivanenko et al. (2006) 
found that the presence of limb movements during sleep was more frequent in children 
with ADHD compared to children with other psychiatric disorders.  Importantly, children 
with ADHD and a comorbid psychiatric disorder were more likely to report sleep 
problems compared to children with ADHD and no comorbidity.  Finally, Mayes et al. 
(2009) concluded that comorbid internalizing disorders increased sleep problems whereas 
comorbid externalizing disorders, such as oppositional defiant disorder, did not.   
It is difficult to draw any definitive conclusions from this small body of literature 
examining sleep problems in children with ADHD and comorbid internalizing and 
externalizing disorders.  All three studies utilized a sample containing only children and 
neglected to examine sleep problems in adolescents.  As Stein et al. (2002) noted, it is 
important to examine sleep problems in adolescents as this age group had the greater 
amount of self-reported sleep problems when compared to children younger than 13 
years.  Further, none of the studies included participants who had both internalizing and 
externalizing comorbid conditions.  Finally, none of the studies controlled for 
demographic characteristics, such as ethnicity and socioeconomic status.    
Contributions of the Proposed Study 
The present study is unique in that it examined diagnosed sleep disorders, sleep 
problems, and medications commonly used to treat sleep disturbance across three 
variables that have been relatively overlooked in previous research: medication, subtype, 
and comorbidity.  Importantly, the proposed study investigated all levels of each variable, 
including stimulant medication, non-stimulant medication, no medication, internalizing 
comorbidity, externalizing comorbidity, internalizing and externalizing comorbidities, no 
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comorbidity, with hyperactivity subtype, and without hyperactivity subtype.  The sample 
was sufficiently large and provided power to detect between-group differences not 
previously identified by other studies with small samples.  Finally, this study included 
children and adolescents in separate analyses, allowing for comparison within age groups 
across the described variables and examined children and adolescents with ADHD in the 





CHAPTER III. METHODS 
Participants and Setting 
 Participants in this study were 11,762 children ages 6 through 18 years old seen 
for a well-child visit within the network of 32 pediatric practices (175 physicians and 22 
nurse practitioners) affiliated with a large tertiary care children’s hospital between 
January 1, 2007 and December 31, 2007.  For children with more than one well-child 
visit during this specified time, only the most recent visit was used.  Participants were 
eligible for inclusion in the study if they had a diagnosis of ADHD documented by their 
primary care provider in their electronic medical file (N = 5,881) or were matched by 
gender, age, and primary care practice without a diagnosis of ADHD (N = 5,881).  
Participants were excluded from this study if they had a diagnosis of an autism spectrum 
disorder or mental retardation. From this sample, 556 participants were randomly 
selected for a more in-depth secondary analysis of sleep problems.  This number of 
participants was chosen based on the recommendation by Pedhazur (1997) that the 
sample size be at least 30 times the number of parameters being estimated.  Please see 
Figure 1 for a visual depiction of the samples used to investigate each research question.         
In most cases, the diagnosis of ADHD was made by the primary care provider 
(PCP) in compliance with the clinical practice guidelines provided by the American 
Academy of Pediatrics (American Academy of Pediatrics, 2000).  The guidelines for 
diagnosis of ADHD in school aged children include: (1) meets the DSM-IV-TR 
(American Psychiatric Association, 2000) or The International Classification of Diseases, 
Ninth Revision, Clinical Modification (ICD-9-CM; National Center for Health Statistics, 
2009) diagnostic criteria; (2) evidence is directly obtained from parents or caregivers and 
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classroom teacher regarding the core symptoms of ADHD in various settings, age of 
onset, duration of symptoms, and degree of functional impairment; and (3) an assessment 
for co-existing difficulties, including motor disability, problems with parent-child 
interaction, and other common psychological disorders, such as conduct and oppositional 
defiant disorder, mood disorders, anxiety disorders, and learning disabilities; however, 
participants diagnosed with these comorbidities will not be excluded from this study. 
In order to provide an estimate of the process by which the diagnosis of ADHD 
was made for participants in this study, the following information was collected from a 
random sample of 556 participants (280 children and 276 adolescents): type of provider 
who made the ADHD diagnosis (primary care provider, psychiatrist, other); presence of a 
broadband rating scale completed by a parent (yes or no); title of the broadband rating 
scale completed by the parent; presence of a narrowband rating scale designed to assess 
symptoms of ADHD completed by a parent (yes or no); title of the narrowband rating 
scale designed to assess symptoms of ADHD completed by a parent; presence of a 
broadband rating scale completed by a teacher (yes or no); title of the broadband rating 
scale completed by the teacher; presence of a narrowband rating scale designed to assess 
symptoms of ADHD completed by a teacher (yes or no); title of the narrowband rating 
scale designed to assess symptoms of ADHD completed by a teacher; structured or 
unstructured interview data collected from a parent (yes or no); and structured or 
unstructured interview data collected from a teacher (yes or no).        
Measures 
The database of demographic and medical variables was provided by the Pediatric 
Research Consortium (PeRC), the department responsible for research using the 
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electronic medical records.  Data extraction for secondary review included the following 
medical and sleep problems obtained through parent and child interview. Medical 
characteristics included comorbid psychiatric diagnoses and current sleep medications.  
Sleep problems are included in the template for well-child visits as options for 
practitioners to select and include the following choices for children 6 to 12 years: 
normal, sleeps through the night, and other; and for adolescents 13 to 18 years: normal, 
sleeps through the night, sleeps from ___ to ___ (times were completed by the PCP), 
difficulty falling asleep, snoring, apnea, nighttime awakenings, daytime sleepiness, and 
other.   
Procedures 
This was a chart review study.  Electronic data were accessed via PeRC for the 
most recent well-child visit from 1/1/2007 to 12/31/2007 for participants ages 6 years to 
18 years seen within the network of Kids First, primary care, and faculty practices.  Well-
child visit records were reviewed for all patients with a diagnosis of ADHD documented 
in their electronic medical file.  For all children, only the most recent well-child visit was 
reviewed.  
The following demographic and medical information was extracted for all 
participants (N = 11,762).  Demographic information included age (classified as 6-12 or 
13-18), gender, race, zip code, and primary care practice.  Patient zip codes were used to 
determine median household income through U.S. Census data, which served as an 
estimate of socioeconomic status.  Medical information included ICD-9 ADHD diagnosis 
(ADHD with hyperactivity, ADHD without mention of hyperactivity, none for 
participants in the comparison sample), ICD-9 sleep diagnosis (insomnia, hypersomnia, 
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parasomnias, restless legs syndrome/periodic limb movement disorder, sleep disordered 
breathing, enuresis, bruxism, circadian rhythm disorder, narcolepsy, sleep disorder not 
otherwise specified), sleep medications (alpha agonists, antidepressants, SSRI’s, 
antihitamines, antipsychotic agents, benzodiazepines, hypnotic agents, and chloral 
hydrate), ADHD medication (stimulant, non-stimulant, none), and comorbidity 
(internalizing, such as anxiety or depression, externalizing, such as oppositional defiant 
disorder or conduct disorder, none).       
From the total sample of children and adolescents with ADHD, 556 participants 
were randomly selected for a more in-depth and manual secondary analysis of parent 
and/or patient complaint of sleep problems.  Parent and/or patient complaint of sleep 
problems were included in the template for well-child visits as options for practitioners to 
select and were coded as change in sleep location, daytime sleepiness, delayed sleep 
schedule, difficulty falling asleep, early morning waking, insufficient sleep, symptoms of 
nocturnal enuresis, parasomnia, poor sleep, restless sleep, RLS symptoms, snoring, use of 
medication, waking during the night, bedtime struggles/limit setting, daytime fatigue, 
insufficient sleep, and none.  Because these data were coded manually, interrater 
reliability was conducted on 20% of participants randomly selected from the total sample.  
Coding was conducted by the investigator and an advanced doctoral level graduate 
student with two years of specialized training in behavioral sleep medicine.  Agreement 
for both subgroups (children ages 6-12 and adolescents ages 13-18) was 100%.  
Data Analysis 
 Descriptive results were provided regarding the demographic information (age, 
gender, race, and zip code) collected from participants.  In addition, frequencies of each 
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type of sleep disorder, sleep medication, sleep problem, and the overlap between these 
three measures of sleep disturbance were reported.  Finally, a description of the process 
by which the diagnosis of ADHD was made for 556 participants was presented in 
frequency form.   
Research Question One. Logistic regression was used to determine the odds 
ratio of diagnosed sleep disorders and prescribed sleep medication in children and 
adolescents.   
In the sample of children (aged 6-12), two logistic regressions were completed.  
The first logistic regression used ADHD diagnosis (yes or no) as the predictor, and sleep 
disorder diagnosis (yes or no) as the outcome measure.  The second logistic regression 
used ADHD diagnosis (yes or no) as the predictor, and prescribed sleep medication (yes 
or no) as the outcome variable.  These analyses were completed with a sample of 6,956 
children (3,478 with ADHD and 3,478 without ADHD), which exceeded the 60 
participants recommended by Pedhazur (1997) to allow the sample size to be at least 30 
times the number of parameters being estimated. 
In the sample of adolescents (aged 13-18), two logistic regressions were 
completed.  The first logistic regression used ADHD diagnosis (yes or no) as the 
predictor, and sleep disorder diagnosis (yes or no) as the outcome measure.  The second 
logistic regression used ADHD diagnosis (yes or no) as the predictor, and prescribed 
sleep medication (yes or no) as the outcome variable.  These analyses were completed 
with a sample of 4,806 adolescents (2,403 with ADHD and 2,403 without ADHD), which 
exceeded the 60 participants recommended by Pedhazur (1997) to allow the sample size 
to be at least 30 times the number of parameters being estimated. 
31 
 
Research Question Two.  Three separate logistic regression analyses were used 
to determine the odds ratio of diagnosed sleep disorders, sleep problems, and prescribed 
sleep medication in children and adolescents.  
In the sample of children (aged 6-12), three logistic regressions were completed.  
The first logistic regression used medication status (no medication, stimulant medication, 
non-stimulant medication, stimulant and non-stimulant medication), ADHD subtype 
(with hyperactivity, without hyperactivity), and comorbidity (no comobidity, 
internalizing comorbidity, externalizing comobidity, and both internalizing and 
externalizing comorbidity) as the predictors, and sleep disorder diagnosis (yes or no) as 
the outcome measure.  The second logistic regression used medication status (no 
medication, stimulant medication, non-stimulant medication), ADHD subtype (with 
hyperactivity, without hyperactivity), and comorbidity (no comobidity, internalizing 
comorbidity, externalizing comobidity, and both internalizing and externalizing 
comorbidity) as the predictors, and prescribed sleep medication (yes or no) as the 
outcome variable.  These analyses were completed with a sample of 3,478 children, 
which exceeded the 270 participants recommended by Pedhazur (1997) to allow the 
sample size to be at least 30 times the number of parameters being estimated.  The third 
logistic regression used medication status (no medication, stimulant medication, non-
stimulant medication, and stimulant and non-stimulant medication), ADHD subtype (with 
hyperactivity, without hyperactivity), and comorbidity (no comobidity, internalizing 
comorbidity, externalizing comobidity, and both internalizing and externalizing 
comorbidity) as the predictors, and sleep problem (yes or no) as the outcome variable.  
These analyses were completed with 280 children.  This met the recommended sample 
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size of at least 30 times the number of parameters being estimated (Pedhazur, 1997) 
except for children with both an internalizing and externalizing comorbidity.  This 
subgroup had a total sample size of 10 children. 
In the sample of adolescents (aged 13-18), three logistic regressions were 
completed.  The first logistic regression used medication status (no medication, stimulant 
medication, non-stimulant medication, stimulant and non-stimulant medication), ADHD 
subtype (with hyperactivity, without hyperactivity), and comorbidity (no comobidity, 
internalizing comorbidity, externalizing comobidity, and both internalizing and 
externalizing comorbidity) as the predictors, and sleep disorder diagnosis (yes or no) as 
the outcome measure.  The second logistic regression used medication status (no 
medication, stimulant medication, non-stimulant medication, stimulant and non-stimulant 
medication), ADHD subtype (with hyperactivity, without hyperactivity), and comorbidity 
(no comobidity, internalizing comorbidity, externalizing comobidity, and both 
internalizing and externalizing comorbidity) as the predictors, and prescribed sleep 
medication (yes or no) as the outcome variable.  These analyses were completed with a 
sample of 2,403 adolescents, which exceeded the 270 participants recommended by 
Pedhazur (1997) to allow the sample size to be at least 30 times the number of parameters 
being estimated.  The third logistic regression used medication status (no medication, 
stimulant medication, non-stimulant medication, stimulant and non-stimulant 
medication), ADHD subtype (with hyperactivity, without hyperactivity), and comorbidity 
(no comobidity, internalizing comorbidity, externalizing comobidity, and both 
internalizing and externalizing comorbidity) as the predictors, and sleep problem (yes or 
no) as the outcome variable.  These analyses were completed with 276 children.  This 
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met the recommended sample size of at least 30 times the number of parameters being 
estimated (Pedhazur, 1997) except for children with both an internalizing and 
externalizing comorbidity.  This subgroup had a total sample size of 6 children. 
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CHAPTER IV. RESULTS 
Demographic Characteristics   
The overall sample of children with ADHD (ages 6-12 years) included 3,378 
participants, with a mean age of 9.44 years (SD = 1.88 years).  This sample was 73.60% 
male, 60.80% White, had a mean estimated median household income of $54,142.63 (SD 
= $20,153.12), and resided in a geographic area with 9.98% (SD = 9.87) of individuals 
living below the poverty line.  For comparison purposes, a second sample of 3,478 
children with no diagnosis of ADHD was matched by age, gender, and primary care 
practice.  This control group had a mean age of 9.44 years (SD = 1.87 years), was 73.6% 
male, 57.6% White, had a mean estimated median household income of $54,048.16 (SD 
= $20,325.25), and resided in a geographic area with 10.28% (SD = 10.10) of individuals 
living below the poverty line.  To further evaluate parent and child reported sleep 
problems, 280 children with ADHD were randomly selected.  The subgroup of children 
with ADHD had a mean age of 9.90 years (SD = 1.87 years), was 73.6% male, 62.5% 
White, had a mean estimated median household income of $54,031.63 (SD = 
$19,442.18), and resided in a geographic area with 10.44% (SD = 10.50) of individuals 
living below the poverty line.   
The overall sample of adolescents with ADHD (ages 13-18 years) included 2,403 
participants, with a mean age of 15.01 years (SD = 1.57 years).  This sample was 69.20% 
male, 69.10% White, had a mean estimated median household income of $58,293.12 (SD 
= $19,608.91), and resided in a geographic area with 8.12% (SD = 8.31) of individuals 
living below the poverty line.  For comparison purposes, a second sample of 2,403 
adolescents with no diagnosis of ADHD was matched by age, gender, and primary care 
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practice.  This control group had a mean age of 15.01 years (SD = 1.57 years), was 
69.20% male, 67.20% White, had a mean estimated median household income of 
$57,806.01 (SD = $19,767.93), and resided in a geographic area with 8.51% (SD = 8.88) 
of individuals living below the poverty line.  To further evaluate parent and child 
reported sleep problems, 276 adolescents with ADHD were randomly selected.  The 
subgroup of adolescents with ADHD had a mean age of 14.92 years (SD = 1.65 years), 
was 71.4% male, 70.3% White, had a mean estimated median household income of 
$57,387.40 (SD = $19,239.46), and resided in a geographic area with 8.74% (SD = 9.37) 
of individuals living below the poverty line.   
Detailed demographic information for all participants is provided in Table 1. 
Frequency of Sleep Diagnoses and Prescribed Sleep Medication  
 Overall Sample of Children with ADHD.  Overall, 8.9% of children with 
ADHD (n = 308) were also diagnosed with a sleep disorder (Table 2).  The most common 
sleep disorder diagnosis was nocturnal enuresis, affecting 4.10% (n = 144) of 
participants.  This was followed by sleep disorder, not otherwise specified (n = 99, 
2.80%), sleep disordered breathing (n = 74, 2.10%), insomnia (n = 14, 0.40%), restless 
legs syndrome/periodic limb movement disorder (n = 2, 0.10%), and parasomnias (n = 1, 
0.01%).  In addition, 16.10% of children with ADHD (n = 559) were prescribed a sleep 
medication (Table 3).  The most common sleep medication was antihistamines, 
prescribed to 7.20% (n = 252) of participants.  This medication was followed by alpha 
agonists (n = 188, 5.40%), antipsychotics (n = 138, 4.00%), melatonin (n = 20, 0.60%), 
SSRI’s (n = 13, 0.40%), benzodiazepines (n = 6, 0.20%), antidepressants (n = 3, 0.10%), 
and chloral hydrate (n = 1, 0.01%).    
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 Control Sample of Children without ADHD. Overall, 4.5% of children without 
ADHD (n = 158) were diagnosed with a sleep disorder (Table 2).  The most common 
sleep disorder diagnosis was nocturnal enuresis, affecting 2.60% (n = 91) of participants.  
This was followed by sleep disorder, not otherwise specified (n = 38, 1.10%), sleep 
disordered breathing (n = 38, 1.10%), insomnia (n = 1, 0.00%), and bruxism (n = 1, 
0.00%).  In addition, 0.50% of children without ADHD (n = 17) were prescribed a sleep 
medication (Table 3).  The most common sleep medications were antipsychotics and 
benzodiazepines, each prescribed to 0.20% (n = 7) of participants.  These medications 
were followed by alpha agonists (n = 2, 0.10%), and SSRI’s (n = 2, 0.10%). 
 Subsample of Children with ADHD.  Overall, 8.21% of randomly selected 
children with ADHD (n = 23) were also diagnosed with a sleep disorder (Table 2).  The 
most common sleep disorder diagnosis was nocturnal enuresis, affecting 4.28% (n = 12) 
of participants.  This was followed by sleep disorder, not otherwise specified (n = 8, 
2.86%), insomnia (n = 3, 1.07%), and sleep disordered breathing (n = 2, 0.71%).  In 
addition, 17.85% of randomly selected children with ADHD (n = 50) were prescribed a 
sleep medication (Table 3).  The most common sleep medication was alpha agonists, 
prescribed to 7.50% (n = 21) of participants.  This medication was followed by 
antipsychotics (n = 13, 4.64%), antihistamines (n = 12, 4.29%), melatonin (n = 5, 1.79%), 
SSRI’s (n = 3, 1.07%), and antidepressants (n = 1, 0.36%).    
Overall Sample of Adolescents with ADHD.  Overall, 5.0% of adolescents with 
ADHD (n = 120) were also diagnosed with a sleep disorder (Table 2).  The most common 
sleep disorder diagnosis was sleep disorder, not otherwise specified, affecting 1.90% (n = 
46) of participants.  This was followed by nocturnal enuresis (n = 43, 1.80%), insomnia 
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(n = 20, 0.80%), sleep disordered breathing (n = 16, 0.70%), circadian rhythm disorder, 
(n = 2, 0.10%), and narcolepsy (n = 2, 0.10%).  In addition, 12.10% of adolescents with 
ADHD (n = 290) were prescribed a sleep medication (Table 3).  The most common sleep 
medication was antihistamines, prescribed to 4.30% (n = 104) of participants.  This 
medication was followed by alpha agonists (n = 88, 3.70%), antipsychotics (n = 71, 
3.00%), SSRI’s (n = 36, 1.50%), benzodiazepines (n = 19, 0.80%), melatonin (n = 9, 
0.40%), hypnotic agents (n = 3, 0.10%), and antidepressants (n = 1, 0.01%).    
 Control Sample of Adolescents without ADHD. Overall, 2.5% of adolescents 
without ADHD (n = 61) were diagnosed with a sleep disorder (Table 2).  The most 
common sleep disorder diagnosis was nocturnal enuresis, affecting 1.00% (n = 25) of 
participants.  This was followed by sleep disorder not otherwise specified (n = 19, 
0.80%), sleep disordered breathing (n = 12, 0.50%), insomnia (n = 3, 0.10%), restless 
legs syndrome and/or periodic limb movement disorder, (n = 3, 0.10%), and circadian 
rhythm disorder (n = 1, 0.00%).  In addition, 0.80% of adolescents without ADHD (n = 
20) were prescribed a sleep medication (Table 3).  The most common sleep medication 
was SSRI’s, prescribed to 0.40% (n = 9) of participants.  This medication was followed 
by benzodiazepines (n = 5, 0.20%), antipsychotics (n = 5, 0.20%), alpha agonists (n = 1, 
0.00%), and hypnotic agents (n = 1, 0.00%). 
Subsample of Adolescents with ADHD.  Overall, 6.5% of randomly selected 
adolescents with ADHD (n = 18) were also diagnosed with a sleep disorder (Table 2).  
The most common sleep disorder diagnosis was sleep disorder, not otherwise specified, 
affecting 4.00% (n = 11) of participants.  This was followed by nocturnal enuresis (n = 5, 
1.80%), and sleep disordered breathing (n = 2, 0.70%).  In addition, 17.00% of children 
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and adolescents with ADHD (n = 47) were prescribed a sleep medication (Table 3).  The 
most common sleep medications were antihistamines and alpha agonists, as both were 
prescribed to 6.20% (n = 17) of participants.  These medications were followed by 
antipsychotics (n = 10, 3.60%), SSRI’s (n = 7, 2.50%), and benzodiazepines (n = 3, 
1.10%).    
Parent and/or Child Reported Sleep Problem and Treatment Recommendations  
 Subsample of Children with ADHD.  Overall, 17.86% of randomly selected 
children with ADHD (n = 50) or their caregivers reported a sleep problem to their 
primary care provider during the well child visit (Table 4).  The most common sleep 
problem was difficulty falling asleep, affecting 9.64% (n = 27) of participants.  This was 
followed by waking during the night (n = 5, 1.79%), poor sleep/does not sleep well (n = 
5, 1.79%), symptoms of nocturnal enuresis (n = 5, 1.79%), change in sleep location (n = 
3, 1.07%), parasomnia (n = 3, 1.07%), bedtime struggles/limit setting (n = 3, 1.07%), 
delayed sleep schedule (n = 2, 0.71%), daytime fatigue (n = 2, 0.71%), early morning 
waking (n = 1, 0.36%), restless sleep (n = 1, 0.36%), snoring (n = 1, 0.36%), daytime 
sleepiness (n = 1, 0.36%), and the use of medication to aid in sleep (n = 1, 0.36%).  Of 
the 50 children with a reported sleep problem, 84% (n = 42) were not provided a 
treatment recommendation by their primary care provider (Table 4).  For those given a 
treatment recommendation, 4.00% (n = 2) were told to use melatonin, 2.00% (n = 1) were 
referred for a PSG, 2.00% (n = 1) were provided with a behavioral sleep 
recommendation, and 8.00% (n = 4) were given an “other” treatment recommendation.       
Subsample of Adolescents with ADHD.  Overall, 14.86% of randomly selected 
adolescents with ADHD (n = 41) or their caregivers reported a sleep problem to their 
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primary care provider during the well child visit (Table 4).  The most common sleep 
problem was difficulty falling asleep, affecting 6.88% (n = 19) of participants.  This was 
followed by waking during the night (n = 10, 3.62%), delayed sleep schedule (n = 5, 
1.81%), daytime sleepiness (n = 4, 1.45%), poor sleep/does not sleep well (n = 4, 1.45%), 
parasomnia (n = 4, 1.45%), use of medication to aid in sleep (n = 3, 1.09%), symptoms of 
nocturnal enuresis (n = 1, 0.36%), restless sleep (n = 1, 0.36%), insufficient sleep (n = 1, 
0.36%), and RLS symptoms (n = 1, 0.36%).  Of the 41 adolescents with a reported sleep 
problem, 87.80% (n = 36) were not provided a treatment recommendation by their 
primary care provider (Table 4).  For those given a treatment recommendation, 4.88% (n 
= 2) were prescribed a medication, 2.44% were referred for a PSG (n = 1), and 4.88% (n 
= 2) were given an “other” treatment recommendation.       
Frequency of Sleep Diagnosis, Sleep Medication, and Sleep Problems Within 
Participants and Across Variables 
 Overall Sample of Children with ADHD.  Of the 308 children with ADHD also 
diagnosed with a sleep disorder, 91.88% (n = 283) were diagnosed with one sleep 
disorder, 7.79% (n = 24) were diagnosed with two sleep disorders, and 0.32% (n = 1) was 
diagnosed with three sleep disorders (Table 5).  Of the 559 children with ADHD also 
prescribed a sleep medication, 89.62% (n = 501) were prescribed one sleep medication, 
10.02% (n = 56) were prescribed two sleep medications, and 0.36% (n = 2) were 
prescribed three sleep medications (Table 5).  Regarding the overlap between sleep 
diagnoses and sleep medications, 55 participants were diagnosed with one sleep disorder 
and prescribed one sleep medication, 12 participants were diagnosed with one sleep 
disorder and prescribed two sleep medications, 5 participants were diagnosed with two 
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sleep disorders and prescribed one sleep medication, and 2 participants were diagnosed 
with two sleep disorders and prescribed two sleep medications (Table 6).       
 Control Sample of Children without ADHD. Of the 308 children without 
ADHD diagnosed with a sleep disorder, 93.70% (n = 148) were diagnosed with one sleep 
disorder, 5.70% (n = 9) were diagnosed with two sleep disorders, and 0.60% (n = 1) was 
diagnosed with three sleep disorders (Table 5).  Of the 17 children without ADHD 
prescribed a sleep medication, 94.10% (n = 16) were prescribed one sleep medication, 
and 5.90% (n = 1) were prescribed two sleep medications (Table 5).  Regarding the 
overlap between sleep diagnoses and sleep medications, three participants were 
diagnosed with one sleep disorder and prescribed one sleep medication (Table 7). 
Subsample of Children with ADHD.  Of the 23 children with ADHD randomly 
selected and also diagnosed with a sleep disorder, 95.65% (n = 22) were diagnosed with 
one sleep disorder and 4.35% (n = 1) was diagnosed with two sleep disorders (Table 5).  
Of the 50 children with ADHD randomly selected and also prescribed a sleep medication, 
90.00% (n = 45) were prescribed one sleep medication and 10.00% (n = 5) were 
prescribed two sleep medications (Table 5).  Of the 51 children with ADHD randomly 
selected and also reported a sleep problem, 72.55% (n = 37) reported one sleep problem, 
and 27.45% (n = 14) reported two sleep problems (Table 5).  Regarding the overlap 
between sleep diagnoses, sleep medications, and sleep problems, two participants were 
diagnosed with one sleep disorder and prescribed one sleep medication, one participant 
was diagnosed with one sleep disorder and prescribed two sleep medications, and one 
participant was diagnosed with two sleep disorders and prescribed one sleep medication 
(Table 8).  In addition, three participants were diagnosed with one sleep disorder and 
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reported one sleep problem, three participants were diagnosed with one sleep disorder 
and reported two sleep problems, and one participant was diagnosed with two sleep 
disorders and reported two sleep problems (Table 8).  Finally, nine participants were 
prescribed one sleep medication and reported one sleep problem, three participants were 
prescribed one sleep medication and reported two sleep problems, and one participant 
was prescribed two sleep medications and reported one sleep problem (Table 8).   
Overall Sample of Adolescents with ADHD.  Of the 120 adolescents with 
ADHD also diagnosed with a sleep disorder, 92.50% (n = 111) were diagnosed with one 
sleep disorder and 7.50% (n = 9) were diagnosed with two sleep disorders (Table 5).  Of 
the 290 adolescents with ADHD also prescribed a sleep medication, 86.90% (n = 252) 
were prescribed one sleep medication, 12.07% (n = 35) were prescribed two sleep 
medications, and 1.03% (n = 3) were prescribed three sleep medications (Table 5).  
Regarding the overlap between sleep diagnoses and sleep medications, 24 participants 
were diagnosed with one sleep disorder and prescribed one sleep medication, 1 
participant was diagnosed with one sleep disorder and prescribed two sleep medications, 
1 participant was diagnosed with one sleep disorder and prescribed three sleep 
medications, 2 participants were diagnosed with two sleep disorders and prescribed one 
sleep medication, and 1 participant was diagnosed with two sleep disorders and 
prescribed two sleep medications (Table 9). 
Control Sample of Adolescents without ADHD. Of the 61 adolescents without 
ADHD diagnosed with a sleep disorder, 96.7% (n = 59) were diagnosed with one sleep 
disorder and 3.30% (n = 2) were diagnosed with two sleep disorders (Table 5).  Of the 20 
adolescents with ADHD also prescribed a sleep medication, 95.50% (n = 19) were 
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prescribed one sleep medication and 5.00% (n = 5) were prescribed two sleep 
medications (Table 5).  Regarding the overlap between sleep diagnoses and sleep 
medications, two participants were diagnosed with one sleep disorder and prescribed one 
sleep medication and one participant was diagnosed with one sleep disorder and 
prescribed two sleep medications (Table 10). 
Subsample of Adolescents with ADHD.  Of the 18 adolescents with ADHD 
randomly selected and also diagnosed with a sleep disorder, 100% (n = 18) were 
diagnosed with one sleep disorder (Table 5).  Of the 47 adolescents with ADHD 
randomly selected and also prescribed a sleep medication, 85.10% (n = 40) were 
prescribed one sleep medication and 14.90% (n = 7) were prescribed two sleep 
medications (Table 5).  Of the 41 adolescents with ADHD randomly selected and also 
reported a sleep problem, 73.20% (n = 30) reported one sleep problem, 24.40% (n = 10) 
reported two sleep problems, and 2.40% (n = 1) reported three sleep problems (Table 5).  
Regarding the overlap between sleep diagnoses, sleep medications, and sleep problems, 
two participants were diagnosed with one sleep disorder and prescribed one sleep 
medication (Table 11).  In addition, five participants were diagnosed with one sleep 
disorder and reported one sleep problem and three participants were diagnosed with one 
sleep disorder and reported two sleep problems (Table 11).  Finally, eight participants 
were prescribed one sleep medication and reported one sleep problem, two participants 
were prescribed one sleep medication and reported two sleep problems, one participant 
was prescribed two sleep medications and reported one sleep problem, and two 




Diagnosis of ADHD Process 
   Subsample of Children with ADHD.  Of the 280 randomly selected children 
with ADHD, 28.90% (n = 37) were diagnosed with ADHD by a psychiatrist (Table 12).  
This was followed by an unknown provider (n = 72, 25.70%), psychologist (n = 46, 
16.40%), primary care physician (n = 37, 13.2%), neurologist (n = 23, 8.2%), and 
developmental pediatrician (n = 21, 7.5%).   
Regarding the 37 children diagnosed with ADHD by their primary care physician, 
8.10% (n = 3) of diagnoses involved the completion of a parent broadband measure, 
5.40% (n = 2) of diagnoses involved the completion of a teacher broadband measure, 
81.10% (n = 30) of diagnoses involved the completion of a parent narrowband measure, 
78.40% (n = 29) of diagnoses involved the completion of a teacher narrowband measure, 
0.00% (n = 0) of diagnoses involved a parent or teacher structured interview, 83.80% (n 
= 31) of diagnoses involved an unstructured parent interview, and 27.00% (n = 10) of 
diagnoses involved an unstructured teacher interview.  Of the 30 parent narrowband 
measures completed, the most common was the NICHQ Vanderbilt Assessment (n = 21, 
70.00%), followed by the Conners Rating Scale (n = 7, 23.30%), and unknown (n = 2, 
6.70%).  Of the 29 teacher narrowband measures completed, the most common was the 
NICHQ Vanderbilt Assessment (n = 21, 72.40%), followed by the Conners Rating Scale 
(n = 6, 20.70%), and unknown (n = 2, 6.90%).  A full description of the process by which 
the diagnosis of ADHD was made by the primary care physician is provided in Table 13.     
 Subsample of Adolescents with ADHD.  Of the 276 randomly selected 
adolescents with ADHD, 45.30% (n = 125) were diagnosed with ADHD by an unknown 
provider (Table 12).  This was followed by a psychiatrist (n = 78, 28.30%), psychologist 
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(n = 30, 10.90%), primary care physician (n = 17, 6.20%), neurologist (n = 16, 5.80%), 
and developmental pediatrician (n = 10, 3.60%).   
Regarding the 17 adolescents diagnosed with ADHD by their primary care 
physician, 58.80% (n = 10) of diagnoses involved the completion of a parent narrowband 
measure, 58.80% (n = 10) of diagnoses involved the completion of a teacher narrowband 
measure, 70.60% (n = 12) of diagnoses involved an unstructured parent interview, 5.90% 
(n = 1) of diagnoses involved an unstructured teacher interview, 0.00% (n = 0) involved 
the completion of a parent or teacher broadband measure, and 0.00% (n = 0) of diagnoses 
involved a parent or teacher structured interview.  Of the 10 parent narrowband measures 
completed, the most common was the NICHQ Vanderbilt Assessment (n = 7, 70.00%), 
followed by the Conners Rating Scale (n = 2, 20.00%), and unknown (n = 1, 10.00%).  
Of the 10 teacher narrowband measures completed, the most common was the NICHQ 
Vanderbilt Assessment (n = 7, 70.00%), followed by the Conners Rating Scale (n = 2, 
20.00%), and unknown (n = 1, 10.00%).  A full description of the process by which the 
diagnosis of ADHD was made by the primary care physician is provided in Table 13.     
Research Question One 
Is ADHD a predictor of sleep disorders and use of sleep medication in children 
(ages 6-12) and adolescents (ages 13-18)? 
 Overall Sample of Children with and without ADHD.  Logistic regression was 
used to determine whether an ADHD diagnosis is predictive of a sleep disorder diagnosis 
or prescribed sleep medication in the overall sample of children with and without ADHD.  
The independent variable entered into the model was ADHD status. 
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 Regarding a sleep disorder diagnosis, analyses revealed that children with ADHD 
were more likely than those without ADHD to be diagnosed with a sleep disorder.  A full 
description of this model is provided in Table 14.   
 Regarding prescribed sleep medication, analyses revealed that children with 
ADHD were more likely to be prescribed a sleep medication.  A full description of this 
model and all independent variables is provided in Table 15.     
 Overall Sample of Adolescents with and without ADHD. Logistic regression 
was used to determine whether an ADHD diagnosis is predictive of a sleep disorder 
diagnosis or prescribed sleep medication in the overall sample of adolescents with and 
without ADHD.  The independent variable entered into the model was ADHD status. 
 Regarding a sleep disorder diagnosis, analyses revealed that adolescents with 
ADHD were more likely than those without ADHD to be diagnosed with a sleep 
disorder.  A full description of this model is provided in Table 16.   
 Regarding prescribed sleep medication, analyses revealed that adolescents with 
ADHD were more likely to be prescribed a sleep medication.  A full description of this 
model and all independent variables is provided in Table 17.     
Research Question Two 
In children (ages 6-12) and adolescents (ages 13-18) with ADHD, to what degree 
are ADHD medication status, ADHD subtype, and psychiatric comorbidity predictive of 
sleep disorders, use of sleep medication, and sleep problems? 
 Overall Sample of Children with ADHD.  Logistic regression was used to 
determine risk factors predictive of a sleep disorder diagnosis or prescribed sleep 
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medication in the overall sample of children with ADHD.  Independent variables entered 
into the model included medication status, ADHD type, and comorbidity. 
 Regarding a sleep disorder diagnosis, analyses revealed that children with ADHD 
with hyperactivity and children with an externalizing comorbidity were more likely to be 
diagnosed with a sleep disorder.  The remaining factors were not predictive of a sleep 
disorder diagnosis.  A full description of this model and all independent variables is 
provided in Table 18.   
 Regarding prescribed sleep medication, analyses revealed that children prescribed 
any type of medication used to treat the symptoms of ADHD (including stimulant, non-
stimulant, and both stimulant and non-stimulant) were more likely to be prescribed a 
sleep medication.  Similarly, children diagnosed with any type of comorbidity (including 
externalizing, internalizing, and both externalizing and internalizing) were more likely to 
be prescribed a sleep medication.  Children diagnosed with ADHD with hyperactivity 
were more likely to be prescribed a sleep medication.  A full description of this model 
and all independent variables is provided in Table 19.     
 Subsample of Children with ADHD.  Logistic regression was used to determine 
risk factors predictive of a reported sleep problem in the subsample of children with 
ADHD.  Independent variables entered into the model included medication status, ADHD 
type, and comorbidity.  Analyses revealed that none of the independent variables were 
predictive of a reported sleep problem.  A full description of this model and all 
independent variables is provided in Table 20. 
 Overall Sample of Adolescents with ADHD.  Logistic regression was used to 
determine risk factors predictive of a sleep disorder diagnosis or prescribed sleep 
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medication in the overall sample of adolescents with ADHD.  Independent variables 
entered into the model included medication status, ADHD type, and comorbidity. 
 Regarding a sleep disorder diagnosis, analyses revealed that adolescents 
diagnosed with an externalizing or externalizing and internalizing comorbidity were more 
likely to be diagnosed with a sleep disorder.  The remaining factors were not predictive of 
a sleep disorder diagnosis.  A full description of this model and all independent variables 
is provided in Table 21.  
 Regarding prescribed sleep medication, analyses revealed that adolescents 
prescribed stimulant or stimulant and non-stimulant medication were more likely to be 
prescribed a sleep medication.  Similarly, adolescents diagnosed with an externalizing or 
internalizing comorbidity were more likely to be prescribed a sleep medication.  Finally, 
adolescents diagnosed with ADHD with hyperactivity were more likely to be prescribed a 
sleep medication.  The remaining factors were not predictive of a prescribed sleep 
medication.  A full description of this model and all independent variables is provided in 
Table 22.      
 Subsample of Adolescents with ADHD.  Logistic regression was used to 
determine risk factors predictive of a reported sleep problem in the subsample of 
adolescents with ADHD.  Independent variables entered into the model included 
medication status, ADHD type, and comorbidity.  Analyses revealed that adolescents 
diagnosed with both an externalizing and internalizing comorbidity were more likely to 
report a sleep problem.  The remaining factors were not predictive of a reported sleep 
problem.  A full description of this model and all independent variables is provided in 
Table 23.     
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CHAPTER V. DISCUSSION 
 
The purpose of this study was to determine the prevalence of sleep disturbance in 
children and adolescents with and without ADHD.  This was accomplished by examining 
diagnosed sleep disorders, medications commonly used to treat sleep disturbance, and 
child and/or caregiver complaint of sleep problems.  In addition, this study explored the 
frequency, type, and significance of sleep disturbance in children and adolescents with 
ADHD across medications used to treat symptoms of ADHD, subtype of ADHD, and 
diagnosed comorbidities.  This information was obtained through electronic medical 
record documentation made by primary care providers during annual well-child visits.   
Research Question One 
 ADHD was found to be a predictor of sleep disorders and use of sleep medication 
in children (ages 6-12) and adolescents (ages 13-18). 
Children and adolescents with ADHD were more likely to have disturbed sleep, 
as measured by ICD-9 sleep disorder diagnosis and prescribed sleep medication, 
compared to their counterparts with no ADHD diagnosis.  Specifically, children and 
adolescents with ADHD were two times more likely to be diagnosed with a sleep 
disorder compared to peers with no ADHD diagnosis.  Children with ADHD were 39 
times more likely and adolescents with ADHD were 16.4 times more likely to be 
prescribed a sleep medication. In addition, significantly more children (8.9%) and 
adolescents (5.0%) with ADHD were also diagnosed with a sleep disorder compared to 
children (4.5%) and adolescents (2.5%) without ADHD.  In addition, the rates of 
medication used to treat sleep disturbance was significantly elevated in children (16.1%) 
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and adolescents (12.1%) with ADHD compared to children (0.5%) and adolescents 
(0.8%) without ADHD. 
  The prevalence of sleep disorders found in the present study was lower than 
previous estimates of 25% to 50% in children and adolescents with ADHD (Corkum, 
Tannock, & Muldofsky, 1998) and 11% to 37% in the general pediatric population 
(Owens et al., 2000).  In previous prevalence studies, rates of sleep disturbance were 
attained through parent and child completed measures specifically designed to screen for 
symptoms of sleep disorders and sleep problems.  In contrast, the present study only 
considered the presence of a previously diagnosed sleep disorder.  Thus, prevalence rates 
in the current study may be an underestimate of sleep disturbance in children and 
adolescents with ADHD and the general pediatric population.   
Although systematically lower across this study, the prevalence of sleep disorders 
across ages is nearly double in the sample of children and adolescents with ADHD 
compared to their counterparts with no diagnosis of ADHD.  This finding indicates an 
increased risk of a comorbid sleep disorder in this population.  At present, the origin of 
this risk increase is unclear.  Individuals diagnosed with ADHD may have intrinsic 
differences in sleep that is associated with this disorder (Golan et al., 2004; Lecendreux et 
al., 2000).  This possible association between symptoms of ADHD and sleep disturbance 
could be related to an underlying neurobehavioral abnormality.  Individuals with ADHD 
may present with a hypoarousal state during the day and a hyperarousal state at night 
(Lecendreux et al., 2000).  In other words, these individuals are more like to fall asleep 
during the day and have increased arousals or waking at night.  In contrast, it is possible 
that sleep disorders may lead to symptoms of ADHD in some children (Chervin, 2001).  
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For example, sleep loss can result in restlessness, irritability, low frustration tolerance, 
and difficulties sustaining attention (Anstead, 2000; Owens, 2005).     
The most common sleep disorders diagnosed in children with ADHD were 
nocturnal enuresis (4.1%) and sleep disorder, NOS (2.8%).  Similarly, nocturnal enuresis 
and sleep disorder, NOS were the most common sleep diagnoses in adolescents with 
ADHD, with prevalence rates of 1.8% and 1.9%, respectively.  Although elevated in the 
sample of individuals with ADHD, the same sleep disorders were the most prevalent in 
the sample of children and adolescents without ADHD.  It is possible that the high 
prevalence of nocturnal enuresis may be attributed to the significant impact this disorder 
poses on family functioning resulting in increased caretaker motivation to report and treat 
this disorder.  The relatively high rates of sleep disorder, NOS could be due to this 
diagnostic code encompassing numerous sleep problems.  The specific symptoms that led 
to this diagnosis are unknown and this diagnosis may serve as a default for primary care 
providers when symptoms or test results do not yield a more specific sleep diagnosis.   
Research Question Two 
 The degree to which ADHD medication status, ADHD subtype, and psychiatric 
comorbidity were predictive of sleep disorders, use of sleep medication, and sleep 
problems in children (ages 6-12) and adolescents (ages 13-18) was determined. 
Medication Status.  Children and adolescents with ADHD prescribed any type of 
medication (stimulant medication, non-stimulant medication, and both stimulant and non-
stimulant medication) designed to treat symptoms of ADHD were more likely to be 
prescribed a medication used to treat sleep disturbance compared to their counterparts not 
prescribed medication designed to treat symptoms of ADHD.  Specifically, children with 
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ADHD prescribed a stimulant and non-stimulant medication were 2.4 times more likely, 
prescribed a stimulant medication were 1.5 times more likely, and prescribed a non-
stimulant were 1.9 times more likely to also be prescribed a sleep medication than 
children with ADHD not prescribed any medication designed to treat symptoms of 
ADHD.  Adolescents with ADHD prescribed a stimulant and non-stimulant medication 
were 2.9 times more likely and prescribed a stimulant medication were 2.6 times more 
likely to also be prescribed a sleep medication than adolescents with ADHD not 
prescribed medication designed to treat symptoms of ADHD.  There were no differences 
in sleep disturbance, as measured by sleep diagnoses and sleep problems, between 
medicated and non-medicated children and adolescents with ADHD.   
These findings are consistent with previous results in the literature that have 
found differences in sleep disturbance as a function of the medication status of children 
and adolescents with ADHD (Corkum et al., 2007; Galland, Tripp, & Taylor, 2010; 
Mayes et al., 2009; Schwartz et al., 2004; Stein, 1999).  In addition, the present study 
highlights the link between prescribed medications used to treat ADHD and increased 
prevalence of prescribed medications used to treat sleep disturbance.  These results 
suggest that children and adolescents prescribed any type of medication used to treat 
ADHD experience increased risk of sleep disturbance that is likely treated with another 
prescription medication.  This finding is not surprising given that the most common side 
effect of stimulant medication is a decreased need for sleep and awareness of fatigue 
(Bricard & Boiden, 2001).  It is unclear why this group of participants was not also 
diagnosed with sleep disorders and/or did not report sleep problems; however, this 
finding may be due to insufficient screening and diagnostic procedures in the primary 
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care setting.  It is also possible that sleep disturbance in children and adolescents with 
ADHD treated with a medication is viewed as an adverse side-effect of stimulant 
medication rather than a sleep disorder that requires further medical or behavioral 
intervention beyond treatment with an additional sleep medication.   
ADHD Subtype.  This study also investigated sleep disturbance across both ICD-
9 ADHD subtypes: ADHD with hyperactivity and ADHD without hyperactivity.  
Children with ADHD with hyperactivity were 1.7 times more likely to be diagnosed with 
a sleep disorder; however, there were no differences found between subtypes in 
adolescents.  Both children and adolescents with ADHD with hyperactivity were 2.5 and 
1.8 times more likely, respectively, to be prescribed a sleep medication.  There were no 
differences found between subtypes when reporting sleep problems across both age 
groups.  Taking into account the relatively low overall prevalence rates of diagnosed 
sleep disorders in the current study, these results suggest there is a difference in sleep 
behavior between subtypes of ADHD with children and adolescents with ADHD with 
hyperactivity experiencing greater sleep disturbance compared to children and 
adolescents with ADHD without hyperactivity.   
It has been well documented that insufficient and/or poor quality sleep may affect 
children and adolescents differently than adults (Anstead, 2000).  For example, rather 
than exhibiting daytime sleepiness and lethargy, children deprived of sleep typically 
demonstrate hyperactivity, restlessness, and difficulty sustaining attention.  This may 
explain why children with ADHD with hyperactivity were more likely to be diagnosed 
with a sleep disorder and were more likely to be prescribed a sleep medication.  As 
adolescents approach adulthood, there may be a shift in the daytime behavior that is 
53 
 
demonstrated while sleep deprived from hyperactivity to lethargy.  This shift in symptom 
expression may result in fewer sleep disorder diagnoses in adolescents with ADHD with 
hyperactivity.  As previous research findings offer conflicting results regarding specific 
differences in sleep disturbance across subtype (Corkum et al., 1999; LeBourgeois et al., 
2004; Lecendruex et al., 2000; Mayes et al., 2009; Willoughby et al., 2008), future 
studies should aim to identify the specific sleep disorders and sleep problems that cause 
insufficient and/or poor quality sleep that children and adolescents with ADHD with 
hyperactivity are more likely to experience. 
Comorbidity.  Previously, few studies had investigated the effect of psychiatric 
comorbidity on sleep disturbance.  The present study found that children with ADHD and 
an externalizing comorbidity were 1.5 times more likely and adolescents with ADHD and 
either an externalizing or internalizing and externalizing comorbidity were 2.5 times and 
12.4 times more likely, respectively, to be diagnosed with a sleep disorder.  These results 
are consistent with previous findings indicating that internalizing and externalizing 
comorbidities are linked to increased rates of sleep disorders (Corkum et al., 1999; 
Ivanenko et al., 2006).  Children with ADHD and either an internalizing, externalizing, or 
both an internalizing and externalizing comorbidity were more likely to be prescribed a 
sleep medication.  Similarly, adolescents with ADHD and either an internalizing or 
externalizing comorbidity were 3.6 and 2.8 times more likely, respectively, to be 
prescribed a sleep medication.  Finally, adolescents with both an internalizing and 
externalizing comorbidity were 12.4 times more likely to report a sleep problem.  This 
finding is somewhat contradictory to Mayes et al. (2009), who concluded that comorbid 
internalizing disorders increased sleep problems whereas comorbid externalizing 
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disorders did not.  This difference may be due to the current study including multiple 
externalizing comorbid disorders, such as conduct disorder and oppositional defiant 
disorder, whereas Mayes et al. (2009) only included oppositional defiant disorder.     
Overall, the results of the present study clearly indicated a strong link between 
both externalizing and internalizing comorbidities and sleep disturbance in this 
population.  The symptoms associated with comorbid disorders may either cause sleep 
disturbance in this population or exacerbate sleep disturbance that is already present.  For 
example, symptoms of anxiety, including excessive worry, feelings of restlessness, and 
difficulty with sleep, and symptoms of depression, including hypersomnia, may lead to a 
sleep disorder diagnosis of insomnia.  Symptoms of oppositional defiant disorder, 
including arguing with adults, defiant behavior, and refusing to comply with demands, 
and symptoms of conduct disorder, including staying out at night despite parental 
prohibitions, may lead to a sleep disorder diagnosis of insufficient sleep, poor sleep 
hygiene, or delayed sleep phase syndrome.  Futures studies should control for 
comorbidity, thereby identifying the relative contribution of ADHD alone to sleep 
disturbance.     
Other Notable Findings   
It is interesting to note the lack of treatment recommendations made by the 
primary care provider after a parent and/or patient complaint of a sleep problem.  In the 
subsample of patients with ADHD, 84% of children and 88% of adolescents or their 
caregivers who reported a sleep problem to their primary care provider and were given no 
treatment recommendation.  The absence of referrals to specialty sleep centers after a 
complaint of a sleep problem may contribute to the low prevalence of diagnosed sleep 
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disorders.  This finding highlights the need for more comprehensive education for 
primary care providers regarding the screening, diagnosis, and treatment of pediatric 
sleep medicine.  Additional awareness is particularly needed for children and adolescents 
with increased risk of sleep disturbance, specifically those patients with ADHD. 
There are several advantages to conducting an electronic medical record review 
within the context of a primary care setting.as it provides a realistic snapshot of current 
care of children and adolescents.  In addition, it identifies under-diagnosing of sleep 
disorders and mental health disorders within the primary setting.  Under-diagnosing of 
these conditions may be due to lack of training or comfort in the diagnostic procedures 
necessary for these disorders.  In addition, time constraints may prohibit primary care 
providers from asking about symptoms related to these disorders.  Further, even if 
patients or caregivers view symptoms of these disorders as problematic, these concerns 
may not be among their top priorities for which to initiate a discussion with the primary 
care physician.   
Sleep disorders, internalizing disorders, and externalizing disorders were under-
diagnosed compared to previous prevalence rates.  As previously discussed, the 
prevalence of sleep disorders within this study was 8.9% in children and 5.0% in 
adolescents, which is well below previous prevalence reports of between 25% and 50% in 
children and adolescents with ADHD (Corkum, Tannock, & Muldofsky, 1998).  
Regarding internalizing disorders across all children and adolescents seen for a well-child 
visit in the 2007 calendar year, 0.09% (N = 70) had a diagnosis of a depressive disorder 
and 0.35% (N = 279) had a diagnosis of an anxiety disorder.  These prevalence rates are 
well below previous estimates of 7.9% for any depressive disorder and 3.8% for any 
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anxiety disorder (Mergl, Seidscheck, Allgaier, Moller, Hegerl, & Henkel, 2007).  
Regarding externalizing disorders, 2.3% (N = 1,816) of children and adolescents seen for 
a well-child visit in the 2007 calendar year were diagnosed with an externalizing 
disorder.  Similarly, the prevalence rates found in the current study are well below 
previous estimates.  Finally, only ADHD diagnoses were found to be greater than 
previous estimates.  Specifically, 7.8% (N = 6,311) of children and adolescents seen for a 
well-child visit within the 2007 calendar year had a diagnosis of ADHD which is within 
the range of previous estimates of between 3% to 5% of school age children (American 
Psychiatric Association, 2000).  These results indicate that primary care providers may 
have difficulty or be less comfortable in identifying sleep disorders, internalizing 
disorders, and externalizing disorders (other than ADHD) within the general pediatric 
population. 
Limitations 
This study has several limitations to consider.  First, the sample in the present 
study varied in ADHD diagnostic evaluation and diagnosing provider, it is impossible to 
rule out the possibility that some individuals were incorrectly diagnosed with ADHD 
based on falsely elevated symptoms of ADHD caused by a sleep disorder.  Similarly, the 
diagnostic process undertaken to evaluate sleep disorders is unknown and there is no way 
to ensure that all diagnoses were made correctly.  Second, there are currently no 
medications to treat sleep disturbances in the pediatric population approved by the Food 
and Drug Administration.  As a result, medications commonly used to treat sleep 
disturbance in adults were used as a proxy method of obtaining prevalence rates.  As 
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such, the current study may have overestimated the rates of prescribed medications to 
treat sleep disturbance.   
There are also several limitation associated with the use of an electronic health 
record for data collection.  Although these procedures are able to provide a realistic 
picture of sleep disturbance in a large sample of children and adolescents with ADHD 
seen in the primary care environment, it is impossible to ensure the integrity of the data 
collection completed by the primary care providers.  Specifically, providers are prompted 
to ask about sleep problems by the well child visit electronic template; however, there are 
no quality control measures in place to ensure that these questions are asked of patients 
and their parents.  In addition, the electronic template varies between children and 
adolescents with the adolescent template providing a greater number of prompts for 
possible sleep problems.  In contrast, the child template provides few prompts and relies 
on the primary care provider to manually type in many sleep problems.  These labor-
intensive procedures may be cumbersome and providers may be more likely to record 
sleep problems in adolescents than children as doing so for the latter is time consuming.   
Finally, the logistic regression analyses were completed with a p-value that was 
not corrected for potential inflation of experiment-wise Type I error.  Although multiple 
statistical procedures may increase the risk of Type I error, the current study identified 
possible risk factors of sleep disturbance and less conservative statistical methods will 
allow providers to identify all possible risk factors.  Use of a corrected p-value may have 
resulted in factors that are predictive of sleep disturbance being incorrectly discounted 
and lead to an increase in Type II error.  In sum, given the exploratory nature of this 
study the use of a p-value that was not corrected is justified in that the harm of 
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discounting truly predictive risk factors is greater than incorrectly identifying variables as 
risk factors of sleep disturbance.   
Clinical Implications 
 ADHD was found to be a predictor of sleep disorders and use of sleep medication 
in both children and adolescents.  As disturbed sleep can result in daytime sleepiness and 
behavioral difficulties that affect cognitive functions, such as attention and memory, as 
well as exacerbate symptoms of ADHD, it is imperative that all clinicians screen for 
sleep disturbance during the assessment for ADHD in order to make the most accurate 
diagnosis.  Further, a comprehensive treatment approach designed to decrease symptoms 
of ADHD must ensure that sleep disturbance is evaluated and, if present, behavioral 
and/or medical strategies are included in the overall treatment approach. 
 In addition, the present study identified specific risk factors of sleep disturbance 
for children and adolescents with ADHD, including medication status, ADHD subtype, 
and comorbid status.  It is important that clinicians are aware of these specific risk factors 
and a more intensive assessment for sleep disturbance that goes beyond a screening 
measure may be warranted with this population.  Finally, the prevalence of sleep 
disorders in the present study was lower than previous estimates.  There was also a lack 
of treatment recommendations made by the primary care provider after a parent and/or 
patient complaint of a sleep problem.  These findings indicate that additional training for 
primary care providers is needed in the assessment and treatment of sleep disturbance in 
children and adolescents with ADHD.   
Directions for Future Research 
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 Identified directions for future research include the development of a screening 
measure to assess sleep disturbance in the population of children of children and 
adolescents with ADHD in the primary care setting.  In addition, a multi-component 
treatment strategy that targets symptoms of ADHD at home and school should include 
the assessment and treatment of sleep disturbance.  The effects of this component should 
be assessed via academic, social, and behavioral outcomes, as well medication status and 
the dosage of medication needed to obtain therapeutic effects.   
Future research should also aim to tease out the predictive contributions of 
internalizing and externalizing comorbidities to sleep disturbance above and beyond the 
predictive contributions of a diagnosis of ADHD.  In the current study, the percentage of 
children with a diagnosed sleep disorder was higher compared to the percentage of 
adolescents diagnosed with a sleep disorder.  Future research should investigate if this is 
a clinically meaningful finding and examine the differences of sleep disturbance between 
children and adolescents in this population.  Finally, the results of this study highlight 
ADHD as a risk factor for sleep disturbance.  This suggests that the association between 
these two medical conditions may be related to a common underlying brain functioning 
factor.  Future research should attempt to determine if this underlying factor exists and 
how it may differ between subtypes of ADHD.  
Conclusion  
In conclusion, the present study highlights the need for screening and appropriate 
treatment recommendations for sleep disturbance in children and adolescents with ADHD 
in the primary care setting.  This is one of the first studies to examine the prevalence of 
sleep disturbance in children and adolescents with ADHD in the primary care setting.  
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Particular emphasis should be placed on early identification of sleep disturbance in 
children and adolescents with ADHD and risk factors identified in the current study, 
including those patients prescribed any type of medication used to treat symptoms of 
ADHD (stimulant, non-stimulant, and stimulant and non-stimulant), those patients 
diagnosed with ADHD with hyperactivity, and those patients with a psychiatric 
comorbidity (internalizing, externalizing, and internalizing and externalizing).  These risk 
factors and their subsequent effects on the severity of symptoms associated with ADHD 








































(N = 276) 
 
Gender, %       
 Male 73.60 73.60 73.60 69.20 69.20 71.40 
 Female 26.40 26.40 26.40 30.80 30.80 28.60 
Age, mean (SD), y 9.44 (1.88) 9.44 (1.88) 9.90 (1.87) 15.01 (1.57) 15.01 (1.57) 14.92 (1.65) 
Race, %       
 Asian 0.60 2.40 1.10 0.40 1.20 0.00 
 Black 29.10 31.90 25.40 20.40 23.40 21.70 
 Hispanic or 
Latino Black 
0.20 0.20 0.00 0.10 0.20 0.00 
 Hispanic or 
Latino Other 
0.80 0.70 0.40 0.90 0.90 1.10 
 Hispanic or 
Latino White 
0.80 0.30 0.70 0.40 0.20 0.00 
 White 60.80 57.60 62.50 69.10 67.20 70.30 
 Other 7.80 7.00 10.00 8.60 6.90 6.90 
Median income,      













Individuals below  9.98 (9.87) 10.28 (10.10) 10.44 (10.50) 8.12 (8.31) 8.51 (8.88) 8.74 (9.37) 
 below poverty 
level, % 
 








































(N = 276) 
 
Sleep Diagnosis  8.90 4.50 8.21 5.00 2.50 6.50 
Sleep Disorder       
 Nocturnal 
Enuresis 
4.10 2.60 4.28 1.80 1.00 1.80 
 Sleep Disorder, 
NOS 




2.10 1.10 0.71 0.70 0.50 0.70 




0.00 0.00 0.00 0.10 0.00 0.00 
 Narcolepsy 0.00 0.00 0.00 0.10 0.00 0.00 
 RLS/PLMD 0.10 0.00 0.00 0.00 0.10 0.00 
 Parasomnia 0.01 0.00 0.00 0.00 0.00 0.00 
 








































(N = 276) 
 
Sleep Medication 16.10 0.50 17.85 12.10 0.80 17.00 
Name of 
Medication 
      
 Antihistamines 7.20 0.00 4.29 4.30 0.00 6.20 
 Alpha Agonists 5.40 0.10 7.50 3.70 0.00 6.20 
 Antipsychotics 4.00 0.20 4.64 3.00 0.20 3.60 
 SSRI’s 0.40 0.10 1.07 1.50 0.40 2.50 
 Melatonin 0.60 0.00 1.79 0.40 0.00 0.00 
 Benzodiazepines 0.20 0.20 0.00 0.80 0.20 1.10 
 Antidepressants 0.10 0.00 0.36 0.01 0.00 0.00 
 Hypnotic 
Agents 
0.00 0.00 0.00 0.10 0.00 0.00 
 Chloral Hydrate 
 











Children with ADHD 
Subgroup 
(N = 280) 
 
 
Adolescents with ADHD 
Subgroup 
(N = 276) 
 
 
Sleep Problem 17.86 14.86 
Type of Sleep Problem   
 Bedtime Struggles/Limit Setting 1.07 0.00 
 Change in Sleep Location 1.07 0.00 
 Daytime Fatigue 0.71 0.00 
 Daytime Sleepiness 0.36 1.45 
 Delayed Sleep Schedule 0.71 1.81 
 Difficulty Falling Asleep 9.64 6.88 
 Early Morning Waking 0.36 0.00 
 Insufficient Sleep 0.00 0.36 
 Symptoms of Nocturnal Enuresis 1.79 0.36 
 Parasomnia 1.07 1.45 
 Poor sleep 1.79 1.45 
 Restless Sleep 0.36 0.36 
 RLS Symptoms 0.00 0.36 
 Snoring 0.36 0.00 
 Use of Medication 0.36 1.09 
 Waking During the Night 1.79 3.62 
Treatment Recommendation   
 Behavioral Sleep Rec. 2.00 0.00 
 Prescribe Medication 0.00 4.88 
 Suggest Melatonin 4.00 0.00 
 Referral for PSG 2.00 2.44 











































(N = 276) 
 
Sleep Disorder   308 158 23 120 61 18 
 Diagnosis, n       
 One Diagnosis, % 91.88 93.70 95.65 92.50 96.70 100.00 
 Two Diagnoses, 
   % 
7.79 5.70 4.35 7.50 3.30 0.00 
 Three Diagnoses,  
   % 
0.32 0.60 0.00 0.00 0.00 0.00 
Prescribed Sleep  559 17 50 290 20 47 
 Medication, n       
 One Medication, 
   % 
89.62 94.10 90.00 86.90 95.50 85.10 
 Two Medications, 
   % 
10.02 5.90 10.00 12.07 5.00 14.90 
 Three 
Medications, % 
0.36 0.00 0.00 1.03 0.00 0.00 
Reported Sleep    51   41 
 Problem, n       
 One Problem, %   72.55   73.20 
 Two Problems, %   27.45   24.40 
 Three Problems, 
   % 
 





Frequency of Sleep Diagnosis and Sleep Medication Across Variables in the Overall Sample of 
Children with ADHD 
 
  
One Sleep Disorder 
Diagnosis 
 






One Prescribed Sleep 
     Medication 
55 5 60 
Two Prescribed Sleep 
     Medications 
12 2 14 







Frequency of Sleep Diagnosis and Sleep Medication Across Variables in the Overall Sample of 
Control Children without ADHD 
 
  





One Prescribed Sleep 
     Medication 
3 3 







Frequency of Sleep Diagnosis and Sleep Medication Across Variables in the Subsample of Children with ADHD 
 
  
One Sleep Disorder 
Diagnosis 
 












One Sleep Disorder 
     Diagnosis 
X X 2 1 3 
Two Sleep Disorder  
     Diagnoses 
X X 1 0 1 
One Prescribed  
     Sleep 
     Medication 
2 1 X X 3 
Two Prescribed 
     Sleep 
     Medications 
1 0 X X 1 
One Reported Sleep 
     Problem 
3 0 9 1 13 
Two Reported Sleep 
     Problems 
3 1 3 0 7 







Frequency of Sleep Diagnosis and Sleep Medication Across Variables in the Overall Sample of 
Adolescents with ADHD 
 
  
One Sleep Disorder 
Diagnosis 
 






One Prescribed Sleep  
     Medication 
24 2 26 
Two Prescribed Sleep 
     Medications 
1 1 2 
Three Prescribed  
     Sleep Medications 
1 0 1 
Total 
 






Frequency of Sleep Diagnosis and Sleep Medication Across Variables in the Overall Sample of 
Control Adolescents without ADHD 
 
  





One Prescribed Sleep  
     Medication 
2 2 
Two Prescribed Sleep 
     Medications 
1 1 







Frequency of Sleep Diagnosis and Sleep Medication Across Variables in the Subsample of Adolescents with ADHD 
 
  
One Sleep Disorder 
Diagnosis 
 












One Sleep Disorder 
     Diagnosis 
X X 2 0 2 
Two Sleep Disorder 
     Diagnoses 
X X 0 0 0 
One Prescribed  
     Sleep  
     Medication 
2 0 X X 3 
Two Prescribed 
     Sleep 
     Medications 
0 0 X X 0 
One Reported Sleep 
     Problem 
5 0 8 1 14 
Two Reported Sleep 
     Problems 
3 0 2 2 7 
Total 
 












Children with ADHD 
Subgroup 
(N = 280) 
 
 
Adolescents with ADHD 
Subgroup 
(N = 276) 
 
 
Type of Provider   
 Developmental Pediatrician 7.50 3.60 
 Neurologist 8.20 5.80 
 Primary Care Physician 13.20 6.20 
 Psychiatrist 28.90 28.30 
 Psychologist 16.40 10.90 






 Table 13 
 





Children with ADHD 
Subgroup,  
Diagnosed by the PCP 
(N = 37) 
 
 
Adolescents with ADHD 
Subgroup,  
Diagnosed by the PCP 
(N = 17) 
 
 
Broadband Measure, %   
 Parent 8.10 0.00 
 Teacher 5.40 0.00 
Narrowband Measure, %   
 Parent 81.10 58.80 
 Teacher 78.40 58.80 
Name of Narrowband Measure   
 Parent, n 30 10 
  Conners Rating Scale, % 23.30 20.00 
  NICHQ Vanderbilt 
Assessment, % 
70.00 70.00 
  Unknown, % 6.70 10.00 
 Teacher, n   
  Conners Rating Scale, % 20.70 20.00 
  NICHQ Vanderbilt 
Assessment, % 
72.40 70.00 
  Unknown, % 6.90 10.00 
Structured Interview, %   
 Parent 0.00 0.00 
 Teacher 0.00 0.00 
Unstructured Interview, %   
 Parent 83.80 70.60 








Logistic Regression Model used to Predict Sleep Disorder Diagnoses in the Sample of Children 









(95% Confidence Interval) 
 
 
ADHD Status   











Logistic Regression Model used to Predict Prescribed Sleep Medication in the Sample of 









(95% Confidence Interval) 
 
 
ADHD Status   










Logistic Regression Model used to Predict Sleep Disorder Diagnoses in the Sample of 









(95% Confidence Interval) 
 
 
ADHD Status   











Logistic Regression Model used to Predict Prescribed Sleep Medication in the Sample of 









(95% Confidence Interval) 
 
 
ADHD Status   











Logistic Regression Model used to Predict Sleep Disorder Diagnoses in the Sample of Children 









(95% Confidence Interval) 
 
 
Type of ADHD Medication   
 Stimulant and Non-Stimulant  -0.261 ± 0.260 0.771 (0.463-1.282) 
 Stimulant -0.124 ± 0.136 0.884 (0.677-1.154) 
 Non-Stimulant  -0.397 ± 0.365 0.672 (0.329-1.376) 
ADHD Diagnosis   
 ADHD with Hyperactivity 0.554± 0.159 1.741 (1.276-2.376)
a
 
Type of Comorbidity   
 Externalizing and Internalizing 0.234 ± 1.060 1.264 (0.158-10.088) 














Logistic Regression Model used to Predict Prescribed Sleep Medication in the Sample of 









(95% Confidence Interval) 
 
 
Type of ADHD Medication   
 Stimulant and Non-Stimulant  0.904 ± 0.183 2.470 (1.727-3.535)
a
 
 Stimulant 0.433 ± 0.121 1.542 (1.217-1.954)
a
 
 Non-Stimulant  0.619 ± 0.249 1.857 (1.139-3.027)
c
 
ADHD Diagnosis   
 ADHD with Hyperactivity 0.925 ± 0.133 2.523 (1.944-3.274)
a
 
Type of Comorbidity   
 Externalizing and Internalizing 1.547 ± 0.645 4.697 (1.326-16.639)
c
 


















Logistic Regression Model used to Predict Sleep Problems in the Sample of Children with 









(95% Confidence Interval) 
 
 
Type of ADHD Medication   
 Stimulant and Non-Stimulant  0.021 ± 0.491 1.021 (0.390-2.671) 
 Stimulant 0.271 ± 0.382 1.311 (0.620-2.772) 
 Non-Stimulant  -0.900 ± 0.672 0.407 (0.109-1.516) 
ADHD Diagnosis   
 ADHD with Hyperactivity -0.197 ± 0.323 0.821 (0.436-1.547) 
Type of Comorbidity   
 Externalizing and Internalizing -0.650 ± 1.085 0.522 (0.062-4.375) 
 Externalizing 0.232 ± 0.436 1.262 (0.537-2.964) 
 Internalizing 
 






Logistic Regression Model used to Predict Sleep Disorder Diagnoses in the Sample of 









(95% Confidence Interval) 
 
 
Type of ADHD Medication   
 Stimulant and Non-Stimulant  0.410 ± 0.351 1.507 (0.757-3.000) 
 Stimulant 0.093 ± 0.232 1.098 (0.697-1.729) 
 Non-Stimulant  -0.577 ± 0.556 0.562 (0.189-1.670) 
ADHD Diagnosis   
 ADHD with Hyperactivity 0.358 ± 0.213 1.431 (0.942-2.173) 
Type of Comorbidity   
 Externalizing and Internalizing 2.520 ± 0.895 12.432 (2.153-71.789)
b
 














Logistic Regression Model used to Predict Prescribed Sleep Medication in the Sample of 









(95% Confidence Interval) 
 
 
Type of ADHD Medication   
 Stimulant and Non-Stimulant  1.077 ± 0.266 2.937 (1.745-4.944)
a
 
 Stimulant 0.942 ± 0.191 2.565 (1.765-3.729)
a
 
 Non-Stimulant  0.504 ± 0.337 1.655 (0.855-3.201) 
ADHD Diagnosis   
 ADHD with Hyperactivity 0.589 ± 0.146 1.802 (1.354-2.400)
a
 
Type of Comorbidity   
 Externalizing and Internalizing 1.430 ± 0.890 4.179 (0.731-23.898) 














Logistic Regression Model used to Predict Sleep Problems in the Sample of Adolescents with 









(95% Confidence Interval) 
 
 
Type of ADHD Medication   
 Stimulant and Non-Stimulant  0.254 ± 0.615 1.289 (0.386-4.306) 
 Stimulant 0.398 ± 0.481 1.488 (0.580-3.818) 
 Non-Stimulant  0.780 ± 0.540 2.182 (0.757-6.288) 
ADHD Diagnosis   
 ADHD with Hyperactivity -0.140 ± 0.348 0.869 (0.440-1.719) 
Type of Comorbidity   
 Externalizing and Internalizing 2.515 ± 0.918 12.365 (2.046-74.721)
a
 
 Externalizing 0.075 ± 0.457  1.078 (0.440-2.640) 
 Internalizing 
 
































N = 5, 881 
Samples used to complete 
analyses for Research 
Question One to predict the 
following variables: 
diagnosed sleep disorder and 
prescribed sleep medication 
Samples used to complete 
analyses for Research 
Question Two to predict the 
following variables: 
diagnosed sleep disorder and 
prescribed sleep medication 
Samples used to: 
1.  Complete analyses 
for Research Question 
Two to predict 
complaint of a sleep 
problem 




N = 11,762 
Adolescents 
w/ ADHD 
N = 2,403 
Children 
w/ ADHD 













N = 276 
Children 
w/ ADHD 
N = 3,478 
Adolescents 
w/ ADHD 
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